Breast Cancer Family Registry

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

A. Antoniou, P. Pharoah, S. Narod, et al.. (2003). American journal of human genetics. Cited 3,763 times. https://doi.org/10.1086/375033

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker, J. Hopper, D. Barnes, et al.. (2017). JAMA. Cited 2,421 times. https://doi.org/10.1001/jama.2017.7112

Genome-wide association study identifies novel breast cancer susceptibility loci

Don M. Conroy, M. Shah, Hannah Munday, et al.. (2007). Nature. Cited 2,346 times. https://doi.org/10.1038/nature05887

Association analysis identifies 65 new breast cancer risk loci

K. Michailidou, S. Lindström, J. Dennis, et al.. (2017). Nature. Cited 1,288 times. https://doi.org/10.1038/nature24284

Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease

T. Möller, Hampus Olsson, J. Ranstam. (2002). The Lancet. Cited 1,250 times. https://doi.org/10.1016/S0140-6736(02)09454-0

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

K. Michailidou, P. Hall, A. González-Neira, et al.. (2013). Nature Genetics. Cited 1,123 times. https://doi.org/10.1038/ng.2563

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease

P. Brandt, R. Goldbohm. (2001). The Lancet. Cited 1,099 times. https://doi.org/10.1016/S0140-6736(01)06524-2

Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

Nobuyuki Hamajima, K. Hirose, K. Tajima, et al.. (2002). British Journal of Cancer. Cited 923 times. https://doi.org/10.1038/sj.bjc.6600596

Gene-panel sequencing and the prediction of breast-cancer risk.

D. Easton, Paul D. P. Pharoah, A. Antoniou, et al.. (2015). The New England journal of medicine. Cited 846 times. https://doi.org/10.1056/NEJMsr1501341

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.

Xiaohong R. Yang, J. Chang-Claude, E. Goode, et al.. (2011). Journal of the National Cancer Institute. Cited 694 times. https://doi.org/10.1093/jnci/djq526

A common coding variant in CASP8 is associated with breast cancer risk

A. Cox, A. Dunning, M. García-Closas, et al.. (2007). Nature Genetics. Cited 592 times. https://doi.org/10.1038/ng1981

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

G. Thomas, K. Jacobs, P. Kraft, et al.. (2009). Nature Genetics. Cited 582 times. https://doi.org/10.1038/ng.353

Detectable clonal mosaicism and its relationship to aging and cancer

K. Jacobs, K. Jacobs, Meredith Yeager, et al.. (2012). Nature genetics. Cited 565 times. https://doi.org/10.1038/ng.2270

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

S. Bojesen, K. Pooley, S. Johnatty, et al.. (2013). Nature Genetics. Cited 561 times. https://doi.org/10.1038/ng.2566

MicroRNA Related Polymorphisms and Breast Cancer Risk

Sofia Khan, Dario Greco, K. Michailidou, et al.. (2014). PLoS ONE. Cited 560 times. https://doi.org/10.1371/journal.pone.0109973

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

N. Mavaddat, D. Barrowdale, I. Andrulis, et al.. (2011). Cancer Epidemiology, Biomarkers & Prevention. Cited 556 times. https://doi.org/10.1158/1055-9965.EPI-11-0775

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

N. Kauff, S. Domchek, T. Friebel, et al.. (2008). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 553 times. https://doi.org/10.1200/JCO.2007.13.9626

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

Shahana Ahmed, G. Thomas, M. Ghoussaini, et al.. (2009). Nature Genetics. Cited 514 times. https://doi.org/10.1038/ng.354

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

A. Antoniou, A. Cunningham, J. Peto, et al.. (2008). British Journal of Cancer. Cited 488 times. https://doi.org/10.1038/sj.bjc.6604305

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

D. Easton, L. McGuffog, D. Thompson, et al.. (2004). American journal of human genetics. Cited 473 times. https://doi.org/10.1086/421251

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

T. S. Frank, S. Manley, O. Olopade, et al.. (1998). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 466 times. https://doi.org/10.1200/JCO.1998.16.7.2417

Genome-wide association studies identify four ER negative–specific breast cancer risk loci

M. García-Closas, F. Couch, S. Lindstrom, et al.. (2013). Nature Genetics. Cited 435 times. https://doi.org/10.1038/ng.2561

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

E. Warner, W. Foulkes, P. Goodwin, et al.. (1999). Journal of the National Cancer Institute. Cited 419 times. https://doi.org/10.1093/JNCI/91.14.1241

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

F. Couch, Xianshu Wang, L. McGuffog, et al.. (2013). PLoS Genetics. Cited 411 times. https://doi.org/10.1371/journal.pgen.1003212

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies

T. Key, P. Appleby, G. Reeves, et al.. (2011). British Journal of Cancer. Cited 397 times. https://doi.org/10.1038/bjc.2011.254

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

M. García-Closas, P. Hall, H. Nevanlinna, et al.. (2008). PLoS Genetics. Cited 392 times. https://doi.org/10.1371/journal.pgen.1000054

RAD51B in Familial Breast Cancer

Liisa M. Pelttari, Sofia Khan, Mikko Vuorela, et al.. (2016). PLoS ONE. Cited 368 times. https://doi.org/10.1371/journal.pone.0153788

Multiple loci with different cancer specificities within the 8q24 gene desert.

M. Ghoussaini, Honglin Song, T. Koessler, et al.. (2008). Journal of the National Cancer Institute. Cited 361 times. https://doi.org/10.1093/jnci/djn190

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

A. Antoniou, Xianshu Wang, Z. Fredericksen, et al.. (2010). Nature Genetics. Cited 358 times. https://doi.org/10.1038/ng.669

The landscape of recombination in African Americans

A. Hinch, Arti Tandon, N. Patterson, et al.. (2011). Nature. Cited 334 times. https://doi.org/10.1038/nature10336

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.

E. John, A. Miron, G. Gong, et al.. (2007). JAMA. Cited 332 times. https://doi.org/10.1001/JAMA.298.24.2869

DNA methylation in white blood cells

M. Terry, L. Delgado-Cruzata, Neomi Vin-Raviv, et al.. (2011). Epigenetics. Cited 329 times. https://doi.org/10.4161/epi.6.7.16500

Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer

S. Loi, R. Milne, M. Friedlander, et al.. (2005). Cancer Epidemiology Biomarkers & Prevention. Cited 324 times. https://doi.org/10.1158/1055-9965.EPI-05-0042

Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27

R. Cesari, E. Martin, G. Calin, et al.. (2003). Proceedings of the National Academy of Sciences of the United States of America. Cited 323 times. https://doi.org/10.1073/pnas.0931262100

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

C. Edlund, A. Ekici, Peter A. Fasching, et al.. (2011). Nature Genetics. Cited 320 times. https://doi.org/10.1038/ng.985

Mammographic density phenotypes and risk of breast cancer: a meta-analysis.

A. Pettersson, R. Graff, G. Ursin, et al.. (2014). Journal of the National Cancer Institute. Cited 313 times. https://doi.org/10.1093/jnci/dju078

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer

E. John, J. Hopper, J. Beck, et al.. (2004). Breast Cancer Research. Cited 309 times. https://doi.org/10.1186/bcr801

Genome-wide association analysis identifies three new breast cancer susceptibility loci

M. Ghoussaini, O. Fletcher, K. Michailidou, et al.. (2012). Nature genetics. Cited 303 times. https://doi.org/10.1038/ng.1049

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.

Yuanshu Dong, Mohamed-Ali Hakimi, Xiaowei Chen, et al.. (2003). Molecular cell. Cited 301 times. https://doi.org/10.1016/S1097-2765(03)00424-6

Key concepts in genetic epidemiology

P. Burton, M. Tobin, J. Hopper. (2005). The Lancet. Cited 294 times. https://doi.org/10.1016/S0140-6736(05)67322-9

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

T. Rebbeck, T. Friebel, E. Friedman, et al.. (2018). Human Mutation. Cited 277 times. https://doi.org/10.1002/humu.23406

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker, L. McGuffog, D. Barrowdale, et al.. (2017). JNCI Journal of the National Cancer Institute. Cited 277 times. https://doi.org/10.1093/jnci/djw302

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

A. Antoniou, A. Spurdle, O. Sinilnikova, et al.. (2008). American journal of human genetics. Cited 277 times. https://doi.org/10.1016/j.ajhg.2008.02.008

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

A. Antoniou, O. Sinilnikova, J. Simard, et al.. (2007). American journal of human genetics. Cited 269 times. https://doi.org/10.1086/522611

Dominant negative ATM mutations in breast cancer families.

G. Chenevix-Trench, A. Spurdle, M. Gatei, et al.. (2002). Journal of the National Cancer Institute. Cited 265 times. https://doi.org/10.1093/JNCI/94.3.205

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations

J. Armes, A. J. Matthew Egan, M. Southey, et al.. (1998). Cancer. Cited 256 times. https://doi.org/10.1002/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N

A Meta-Analysis Identifies New Loci Associated with Body Mass index in Individuals of African Ancestry

K. Monda, K. Monda, Gary K. Chen, et al.. (2013). Nature genetics. Cited 255 times. https://doi.org/10.1038/ng.2608

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.

J. Armes, L. Trute, David M. White, et al.. (1999). Cancer research. Cited 246 times.

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

E. Bancroft, E. Page, E. Castro, et al.. (2014). European Urology. Cited 243 times. https://doi.org/10.1016/j.eururo.2014.01.003

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.

J. French, M. Ghoussaini, S. Edwards, et al.. (2013). American journal of human genetics. Cited 235 times. https://doi.org/10.1016/j.ajhg.2013.01.002

Classification of rare missense substitutions, using risk surfaces, with genetic‐ and molecular‐epidemiology applications

S. Tavtigian, G. Byrnes, D. Goldgar, et al.. (2008). Human Mutation. Cited 234 times. https://doi.org/10.1002/humu.20896

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients

H. Özçelik, B. Schmocker, N. Nicola, et al.. (1997). Nature Genetics. Cited 232 times. https://doi.org/10.1038/NG0597-17

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

Yan Guo, Shaneda Warren Andersen, X. Shu, et al.. (2016). PLoS Medicine. Cited 229 times. https://doi.org/10.1371/journal.pmed.1002105

Rare variants in the ATM gene and risk of breast cancer

D. Goldgar, S. Healey, J. Dowty, et al.. (2011). Breast Cancer Research : BCR. Cited 227 times. https://doi.org/10.1186/bcr2919

Activation of Notch signaling in human colon adenocarcinoma.

M. Reedijk, S. Odorcic, Hui Zhang, et al.. (2008). International journal of oncology. Cited 224 times. https://doi.org/10.3892/IJO_00000112

Genetic evidence and integration of various data sources for classifying uncertain variants into a single model

D. Goldgar, D. Easton, G. Byrnes, et al.. (2008). Human Mutation. Cited 203 times. https://doi.org/10.1002/humu.20897

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

A. Antoniou, J. Beesley, L. McGuffog, et al.. (2010). Cancer research. Cited 201 times. https://doi.org/10.1158/0008-5472.CAN-10-1907

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers

A. Eisen, J. Lubiński, J. Gronwald, et al.. (2008). JNCI Journal of the National Cancer Institute. Cited 198 times. https://doi.org/10.1093/jnci/djn313

Identification of Novel Genetic Markers of Breast Cancer Survival

Qi Guo, M. Schmidt, P. Kraft, et al.. (2015). JNCI Journal of the National Cancer Institute. Cited 195 times. https://doi.org/10.1093/jnci/djv081

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

G. Wishart, C. Bajdik, E. Dicks, et al.. (2012). British Journal of Cancer. Cited 192 times. https://doi.org/10.1038/bjc.2012.338

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

A. Broeks, M. Schmidt, M. Sherman, et al.. (2011). Human molecular genetics. Cited 192 times. https://doi.org/10.1093/hmg/ddr228

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

(2012). JAMA. Cited 191 times. https://doi.org/10.1001/jama.2012.20

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.

Maren Weischer, B. Nordestgaard, P. Pharoah, et al.. (2012). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 190 times. https://doi.org/10.1200/JCO.2012.42.7336

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

A. Siddiq, F. Couch, Gary K. Chen, et al.. (2012). Human molecular genetics. Cited 189 times. https://doi.org/10.1093/hmg/dds381

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

C. Maxwell, J. Benítez, L. Gómez-Baldó, et al.. (2011). PLoS Biology. Cited 188 times. https://doi.org/10.1371/journal.pbio.1001199

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

G. Dite, M. Jenkins, M. Southey, et al.. (2003). Journal of the National Cancer Institute. Cited 188 times. https://doi.org/10.1093/JNCI/95.6.448

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.

K. Phillips, R. Milne, M. Rookus, et al.. (2013). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 183 times. https://doi.org/10.1200/JCO.2012.47.8313

Rare mutations in XRCC2 increase the risk of breast cancer.

Daniel J. Park, F. Lesueur, T. Nguyen-Dumont, et al.. (2012). American journal of human genetics. Cited 182 times. https://doi.org/10.1016/j.ajhg.2012.02.027

Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

S. Tavtigian, P. Oefner, D. Babikyan, et al.. (2009). American journal of human genetics. Cited 181 times. https://doi.org/10.1016/j.ajhg.2009.08.018

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

S. Kar, J. Beesley, Ali Amin Al Olama, et al.. (2016). Cancer discovery. Cited 180 times. https://doi.org/10.1158/2159-8290.CD-15-1227

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

M. Schmidt, F. Hogervorst, R. van Hien, et al.. (2016). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 176 times. https://doi.org/10.1200/JCO.2016.66.5844

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)

G. Chenevix-Trench, R. Milne, A. Antoniou, et al.. (2007). Breast Cancer Research. Cited 176 times. https://doi.org/10.1186/bcr1670

Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.

P. Pharoah. (2007). Journal of the National Cancer Institute. Cited 176 times. https://doi.org/10.1093/JNCI/DJK099

Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

S. Nickels, Thérèse Truong, R. Hein, et al.. (2013). PLoS Genetics. Cited 173 times. https://doi.org/10.1371/journal.pgen.1003284

Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

G. Chenevix-Trench, S. Healey, S. Lakhani, et al.. (2006). Cancer research. Cited 172 times. https://doi.org/10.1158/0008-5472.CAN-05-3546

BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays

A. Bane, J. Beck, I. Bleiweiss, et al.. (2007). The American Journal of Surgical Pathology. Cited 171 times. https://doi.org/10.1097/01.pas.0000213351.49767.0f

Misclassification of race/ethnicity in a Population-based Cancer Registry (United States)

S. Gomez, S. Glaser. (2006). Cancer Causes & Control. Cited 171 times. https://doi.org/10.1007/s10552-006-0013-y

Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors.

S. Winter, L. Bosnoyan-Collins, Dushanthi Pinnaduwage, et al.. (2007). Neoplasia. Cited 170 times. https://doi.org/10.1593/NEO.07595

SNP-SNP interactions in breast cancer susceptibility

Venus Onay, L. Briollais, J. Knight, et al.. (2006). BMC Cancer. Cited 169 times. https://doi.org/10.1186/1471-2407-6-114

Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer

E. Wong, M. Southey, S. Fox, et al.. (2010). Cancer Prevention Research. Cited 166 times. https://doi.org/10.1158/1940-6207.CAPR-10-0212

A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.

Wendy Wang, A. Spurdle, P. Kolachana, et al.. (2001). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 165 times.

Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.

P. Goodwin, K. Phillips, D. West, et al.. (2012). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 162 times. https://doi.org/10.1200/JCO.2010.33.0068

Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research

M. B. Terry, Karin B. Michels, J. Brody, et al.. (2019). Breast Cancer Research : BCR. Cited 162 times. https://doi.org/10.1186/s13058-019-1168-2

Population-based family studies in genetic epidemiology

J. Hopper, D. Bishop, D. Easton. (2005). The Lancet. Cited 161 times. https://doi.org/10.1016/S0140-6736(05)67570-8

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

A. Whittemore, R. Balise, P. Pharoah, et al.. (2004). British Journal of Cancer. Cited 159 times. https://doi.org/10.1038/sj.bjc.6602239

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

M. Gaudet, T. Kirchhoff, Todd Green, et al.. (2010). PLoS Genetics. Cited 158 times. https://doi.org/10.1371/journal.pgen.1001183

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.

J. Sampson, W. Wheeler, M. Yeager, et al.. (2015). Journal of the National Cancer Institute. Cited 153 times. https://doi.org/10.1093/jnci/djv279

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

A. Antoniou, P. Pharoah, S. Narod, et al.. (2005). Journal of Medical Genetics. Cited 153 times. https://doi.org/10.1136/jmg.2004.024133

Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

F. Candido-dos-Reis, Honglin Song, E. Goode, et al.. (2014). Clinical Cancer Research. Cited 151 times. https://doi.org/10.1158/1078-0432.CCR-14-2497

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

A. Dunning, K. Michailidou, Karoline B. Kuchenbaecker, et al.. (2016). Nature Genetics. Cited 150 times. https://doi.org/10.1038/ng.3521

Short telomere length and breast cancer risk: a study in sister sets.

Jing Shen, M. Terry, I. Gurvich, et al.. (2007). Cancer research. Cited 149 times. https://doi.org/10.1158/0008-5472.CAN-06-3490

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

J. Weitzel, J. Clague, A. Martir-Negron, et al.. (2013). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 148 times. https://doi.org/10.1200/JCO.2011.41.0027

A genome wide linkage search for breast cancer susceptibility genes

Paula L. Smith, L. McGuffog, D. Easton, et al.. (2006). Genes. Cited 147 times. https://doi.org/10.1002/gcc.20330

Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study

A. Antoniou, M. Rookus, N. Andrieu, et al.. (2009). Cancer Epidemiology Biomarkers & Prevention. Cited 146 times. https://doi.org/10.1158/1055-9965.EPI-08-0546

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer.

A. Spurdle, B. Goodwin, Ecushla Hodgson, et al.. (2002). Pharmacogenetics. Cited 146 times. https://doi.org/10.1097/00008571-200207000-00003

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.

Ali Amin Al Olama, Z. Kote-Jarai, F. Schumacher, et al.. (2013). Human molecular genetics. Cited 141 times. https://doi.org/10.1093/hmg/dds425

Communication of BRCA1 and BRCA2 results to at‐risk relatives: A cancer risk assessment program's experience

J. Costalas, M. Itzen, J. Malick, et al.. (2003). American Journal of Medical Genetics Part C: Seminars in Medical Genetics. Cited 139 times. https://doi.org/10.1002/ajmg.c.10003

Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study

Chenan Zhang, J. Doherty, S. Burgess, et al.. (2015). Human Molecular Genetics. Cited 138 times. https://doi.org/10.1093/hmg/ddv252

Enhanced Statistical Tests for GWAS in Admixed Populations: Assessment using African Americans from CARe and a Breast Cancer Consortium

B. Pasaniuc, B. Pasaniuc, Noah Zaitlen, et al.. (2011). PLoS Genetics. Cited 138 times. https://doi.org/10.1371/journal.pgen.1001371

Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25

L. Fejerman, N. Ahmadiyeh, D. Hu, et al.. (2014). Nature Communications. Cited 135 times. https://doi.org/10.1038/ncomms6260

Oral Contraceptive Use and Risk of Early-Onset Breast Cancer in Carriers and Noncarriers of BRCA1 and BRCA2 Mutations

R. Milne, J. Knight, E. John, et al.. (2005). Cancer Epidemiology Biomarkers & Prevention. Cited 134 times. https://doi.org/10.1158/1055-9965.EPI-04-0376

Expression of constitutively activated EGFRvlll in non‐small cell lung cancer

I. Okamoto, L. Kenyon, D. Emlet, et al.. (2003). Cancer Science. Cited 134 times. https://doi.org/10.1111/j.1349-7006.2003.tb01351.x

10-year performance of four models of breast cancer risk: a validation study.

M. Terry, Y. Liao, A. Whittemore, et al.. (2019). The Lancet. Oncology. Cited 130 times. https://doi.org/10.1016/S1470-2045(18)30902-1

Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry

A. Mulligan, Irene Raitman, L. Feeley, et al.. (2012). Clinical Cancer Research. Cited 129 times. https://doi.org/10.1158/1078-0432.CCR-11-3314

Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

M. Gaudet, Karoline B. Kuchenbaecker, J. Vijai, et al.. (2013). PLoS Genetics. Cited 128 times. https://doi.org/10.1371/journal.pgen.1003173

Dietary patterns and risk of breast cancer

L. Baglietto, L. Baglietto, K. Krishnan, et al.. (2010). British Journal of Cancer. Cited 127 times. https://doi.org/10.1038/sj.bjc.6606044

Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites.

A. Whittemore, G. Gong, E. John, et al.. (2004). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 127 times. https://doi.org/10.1158/1055-9965.2078.13.12

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

J. Cui, A. Antoniou, G. Dite, et al.. (2001). American journal of human genetics. Cited 126 times. https://doi.org/10.1086/318187

A role for the TGFβ-Par6 polarity pathway in breast cancer progression

A. Viloria‐Petit, L. David, J. Jia, et al.. (2009). Proceedings of the National Academy of Sciences. Cited 125 times. https://doi.org/10.1073/pnas.0906796106

A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center

C. Gilpin, N. Carson, A. Hunter. (2000). Clinical Genetics. Cited 125 times. https://doi.org/10.1034/j.1399-0004.2000.580408.x

Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium

M. Ng, M. Graff, Yingchang Lu, et al.. (2017). PLoS Genetics. Cited 124 times. https://doi.org/10.1371/journal.pgen.1006719

BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50

R. Haile, Duncan C. Thomas, V. McGuire, et al.. (2006). Cancer Epidemiology Biomarkers & Prevention. Cited 124 times. https://doi.org/10.1158/1055-9965.EPI-06-0258

Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors.

A. Frolov, S. Chahwan, M. Ochs, et al.. (2003). Molecular cancer therapeutics. Cited 124 times.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

A. Osorio, R. Milne, Karoline B. Kuchenbaecker, et al.. (2014). PLOS Genetics. Cited 123 times. https://doi.org/10.1371/journal.pgen.1004256

The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women

R. Osborne, G. Elsworth, M. Sprangers, et al.. (2004). Quality of Life Research. Cited 123 times. https://doi.org/10.1023/B:QURE.0000015292.56268.e7

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

Ben Zhang, X. Shu, Ryan J. Delahanty, et al.. (2015). Journal of the National Cancer Institute. Cited 122 times. https://doi.org/10.1093/jnci/djv219

Genetic ancestry and risk of breast cancer among U.S. Latinas.

L. Fejerman, E. John, S. Huntsman, et al.. (2008). Cancer research. Cited 122 times. https://doi.org/10.1158/0008-5472.CAN-08-2039

A PALB2 mutation associated with high risk of breast cancer

M. Southey, Z. L. Teo, J. Dowty, et al.. (2010). Breast Cancer Research : BCR. Cited 121 times. https://doi.org/10.1186/bcr2796

Functional assays for classification of BRCA2 variants of uncertain significance.

Daniel J. Farrugia, M. Agarwal, V. Pankratz, et al.. (2008). Cancer research. Cited 120 times. https://doi.org/10.1158/0008-5472.CAN-07-1587

Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations.

D. Gaffney, R. Brohet, C. Lewis, et al.. (1998). Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. Cited 120 times. https://doi.org/10.1016/S0167-8140(98)00023-1

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

K. Meyer, M. O’Reilly, K. Michailidou, et al.. (2013). American journal of human genetics. Cited 119 times. https://doi.org/10.1016/j.ajhg.2013.10.026

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

Kristen Stevens, Z. Fredericksen, C. Vachon, et al.. (2012). Cancer research. Cited 119 times. https://doi.org/10.1158/0008-5472.CAN-11-3364

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

A. Antoniou, O. Sinilnikova, L. McGuffog, et al.. (2009). Human molecular genetics. Cited 119 times. https://doi.org/10.1093/hmg/ddp372

Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study

T. Longacre, M. Ennis, Louise A. Quenneville, et al.. (2006). Modern Pathology. Cited 119 times. https://doi.org/10.1038/modpathol.3800496

Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.

R. Milne, J. Benítez, H. Nevanlinna, et al.. (2009). Journal of the National Cancer Institute. Cited 118 times. https://doi.org/10.1093/jnci/djp167

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

D. Easton, F. Lesueur, B. Decker, et al.. (2016). Journal of Medical Genetics. Cited 116 times. https://doi.org/10.1136/jmedgenet-2015-103529

Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

A. Spurdle, F. Couch, M. Parsons, et al.. (2014). Breast Cancer Research : BCR. Cited 114 times. https://doi.org/10.1186/s13058-014-0474-y

Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk

C. Vachon, C. Scott, P. Fasching, et al.. (2012). Cancer Epidemiology, Biomarkers & Prevention. Cited 113 times. https://doi.org/10.1158/1055-9965.EPI-12-0066

Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry.

K. Phillips, R. Milne, S. Buys, et al.. (2005). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 113 times. https://doi.org/10.1200/JCO.2005.03.002

Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.

Anu Gupta, A. Godwin, L. Vanderveer, et al.. (2003). Cancer research. Cited 113 times.

Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study

F. Damiola, M. Pertesi, J. Oliver, et al.. (2014). Breast Cancer Research : BCR. Cited 112 times. https://doi.org/10.1186/bcr3669

Common variants in ZNF365 are associated with both mammographic density and breast cancer risk

(2011). Nature genetics. Cited 112 times. https://doi.org/10.1038/ng.760

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.

K. Phillips, K. Nichol, H. Ozçelik, et al.. (1999). Journal of the National Cancer Institute. Cited 112 times. https://doi.org/10.1093/JNCI/91.5.469

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

F. Couch, Karoline B. Kuchenbaecker, K. Michailidou, et al.. (2016). Nature Communications. Cited 110 times. https://doi.org/10.1038/ncomms11375

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Valentina Silvestri, D. Barrowdale, A. Mulligan, et al.. (2016). Breast Cancer Research : BCR. Cited 107 times. https://doi.org/10.1186/s13058-016-0671-y

Impact of Neighborhood and Individual Socioeconomic Status on Survival after Breast Cancer Varies by Race/Ethnicity: The Neighborhood and Breast Cancer Study

Salma Shariff-Marco, Juan Yang, E. John, et al.. (2014). Cancer Epidemiology, Biomarkers & Prevention. Cited 107 times. https://doi.org/10.1158/1055-9965.EPI-13-0924

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

A. Mulligan, F. Couch, D. Barrowdale, et al.. (2011). Breast Cancer Research : BCR. Cited 106 times. https://doi.org/10.1186/bcr3052

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study

R. Milne, M. Gaudet, A. Spurdle, et al.. (2010). Breast Cancer Research : BCR. Cited 106 times. https://doi.org/10.1186/bcr2797

Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium

Deborah J. Thompson, C. Szabo, J. Mangion, et al.. (2002). Proceedings of the National Academy of Sciences of the United States of America. Cited 104 times. https://doi.org/10.1073/pnas.012584499

Genome-wide meta-analyses of smoking behaviors in African Americans

S. David, S. David, S. David, et al.. (2012). Translational Psychiatry. Cited 103 times. https://doi.org/10.1038/tp.2012.41

Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.

J. Figueiredo, J. Knight, L. Briollais, et al.. (2004). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 103 times. https://doi.org/10.1158/1055-9965.583.13.4

Altered expression of the septin gene, SEPT9, in ovarian neoplasia

J. F. Burrows, S. Chanduloy, M. Mcilhatton, et al.. (2003). The Journal of Pathology. Cited 103 times. https://doi.org/10.1002/path.1484

Two Susceptibility Loci Identified for Prostate Cancer Aggressiveness

S. Berndt, Zhaoming Wang, M. Yeager, et al.. (2015). Nature communications. Cited 102 times. https://doi.org/10.1038/ncomms7889

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

K. Phillips, I. Andrulis, Pamela J. Goodwin. (1999). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 101 times. https://doi.org/10.1200/JCO.1999.17.11.3653

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.

G. Fehringer, P. Kraft, P. Pharoah, et al.. (2016). Cancer research. Cited 100 times. https://doi.org/10.1158/0008-5472.CAN-15-2980

Population‐based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066–6T>G (IVS10–6T>G) from the Breast Cancer Family Registry

J. Bernstein, S. Teraoka, M. Southey, et al.. (2006). Human Mutation. Cited 100 times. https://doi.org/10.1002/humu.20415

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.

L. Prospero, M. Seminsky, Joanne Honeyford, et al.. (2001). CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. Cited 100 times.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

A. Antoniou, Karoline B. Kuchenbaecker, P. Soucy, et al.. (2012). Breast Cancer Research : BCR. Cited 99 times. https://doi.org/10.1186/bcr3121

DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.

D. Kennedy, Meenakshi Agrawal, Jing Shen, et al.. (2005). Journal of the National Cancer Institute. Cited 99 times. https://doi.org/10.1093/JNCI/DJI013

Identification, Replication, and Fine-Mapping of Loci Associated with Adult Height in Individuals of African Ancestry

A. N’Diaye, Gary K. Chen, Cameron D. Palmer, et al.. (2011). PLoS Genetics. Cited 98 times. https://doi.org/10.1371/journal.pgen.1002298

Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry

G. Dite, R. MacInnis, A. Bickerstaffe, et al.. (2015). Cancer Epidemiology, Biomarkers & Prevention. Cited 97 times. https://doi.org/10.1158/1055-9965.EPI-15-0838

Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).

J. Hopper, G. Chenevix-Trench, D. Jolley, et al.. (1999). Journal of the National Cancer Institute. Monographs. Cited 97 times. https://doi.org/10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A024232

DDT and Breast Cancer: Prospective Study of Induction Time and Susceptibility Windows

B. Cohn, P. Cirillo, M. Terry. (2019). JNCI Journal of the National Cancer Institute. Cited 96 times. https://doi.org/10.1093/jnci/djy198

European Ancestry Is Positively Associated with Breast Cancer Risk in Mexican Women

L. Fejerman, I. Romieu, E. John, et al.. (2010). Cancer Epidemiology, Biomarkers & Prevention. Cited 95 times. https://doi.org/10.1158/1055-9965.EPI-09-1193

The role of genetic breast cancer susceptibility variants as prognostic factors.

P. Fasching, P. Pharoah, A. Cox, et al.. (2012). Human molecular genetics. Cited 94 times. https://doi.org/10.1093/hmg/dds159

Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study

F. Le Calvez-Kelm, F. Lesueur, F. Damiola, et al.. (2011). Breast Cancer Research : BCR. Cited 94 times. https://doi.org/10.1186/bcr2810

Pathobiologic characteristics of hereditary breast cancer.

B. Lynch, J. Holden, S. Buys, et al.. (1998). Human pathology. Cited 93 times. https://doi.org/10.1016/S0046-8177(98)90427-0

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.

J. Figueroa, M. García-Closas, Manjeet K. Humphreys, et al.. (2011). Human molecular genetics. Cited 92 times. https://doi.org/10.1093/hmg/ddr368

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

Dylan M Glubb, M. Maranian, K. Michailidou, et al.. (2015). American journal of human genetics. Cited 91 times. https://doi.org/10.1016/j.ajhg.2014.11.009

Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.

C. D. Capo-chichi, I. Roland, L. Vanderveer, et al.. (2003). Cancer research. Cited 91 times.

Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry

E. Mocci, R. Milne, Elena Yuste Méndez-Villamil, et al.. (2013). Cancer Epidemiology, Biomarkers & Prevention. Cited 90 times. https://doi.org/10.1158/1055-9965.EPI-12-0195

A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

C. Fang, C. Cherry, K. Devarajan, et al.. (2009). Gynecologic oncology. Cited 90 times. https://doi.org/10.1016/j.ygyno.2008.11.039

Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer

P. Webb, J. Hopper, B. Newman, et al.. (2005). Cancer Epidemiology Biomarkers & Prevention. Cited 90 times. https://doi.org/10.1158/1055-9965.EPI-04-0335

Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study.

K. Phillips, R. Osborne, G. Giles, et al.. (2008). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 89 times. https://doi.org/10.1200/JCO.2007.14.8718

Genetic Variants of GPX1 and SOD2 and Breast Cancer Risk at the Ontario Site of the Breast Cancer Family Registry

J. Knight, U. V. Onay, Sean Wells, et al.. (2004). Cancer Epidemiology Biomarkers & Prevention. Cited 87 times. https://doi.org/10.1158/1055-9965.EPI-03-0164

Second to fourth digit ratio (2D : 4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study

David C. Muller, David C. Muller, L. Baglietto, et al.. (2012). British Journal of Cancer. Cited 86 times. https://doi.org/10.1038/bjc.2012.418

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

A. Antoniou, Christiana Kartsonaki, O. Sinilnikova, et al.. (2011). Human molecular genetics. Cited 86 times. https://doi.org/10.1093/hmg/ddr226

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age

H. Ahsan, J. Halpern, M. Kibriya, et al.. (2014). Cancer Epidemiology, Biomarkers & Prevention. Cited 85 times. https://doi.org/10.1158/1055-9965.EPI-13-0340

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

K. Schrader, S. Masciari, Niki Boyd, et al.. (2010). Journal of Medical Genetics. Cited 85 times. https://doi.org/10.1136/jmg.2010.079814

Admixture Mapping of 15,280 African Americans Identifies Obesity Susceptibility Loci on Chromosomes 5 and X

Ching-Yu Cheng, Ching-Yu Cheng, W. Kao, et al.. (2009). PLoS Genetics. Cited 85 times. https://doi.org/10.1371/journal.pgen.1000490

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

A. Spurdle, G. Dite, Xiaoqing Chen, et al.. (1999). Journal of the National Cancer Institute. Cited 85 times. https://doi.org/10.1093/JNCI/91.11.961

Comparison of DNA‐ and RNA‐Based Methods for Detection of Truncating BRCA1 Mutations

I. Andrulis, H. Anton-Culver, J. Beck, et al.. (2002). Human Mutation. Cited 83 times. https://doi.org/10.1002/humu.10097

Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.

A. Spurdle, S. Lakhani, S. Healey, et al.. (2008). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 82 times. https://doi.org/10.1200/JCO.2007.13.2779

Genetic modifiers of CHEK2*1100delC associated breast cancer risk

T. Muranen, Dario Greco, C. Blomqvist, et al.. (2016). Genetics in medicine : official journal of the American College of Medical Genetics. Cited 81 times. https://doi.org/10.1038/gim.2016.147

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Huong D. Meeks, Honglin Song, K. Michailidou, et al.. (2016). Journal of the National Cancer Institute. Cited 81 times. https://doi.org/10.1093/jnci/djv315

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Hermela Shimelis, R. Mesman, Catharina von Nicolai, et al.. (2017). Cancer research. Cited 80 times. https://doi.org/10.1158/0008-5472.CAN-16-2568

A genome-wide association study of breast cancer in women of African ancestry

Fang Chen, Gary K. Chen, D. Stram, et al.. (2012). Human Genetics. Cited 80 times. https://doi.org/10.1007/s00439-012-1214-y

Dietary isoflavone intake and all‐cause mortality in breast cancer survivors: The Breast Cancer Family Registry

F. Zhang, D. Haslam, M. Terry, et al.. (2017). Cancer. Cited 79 times. https://doi.org/10.1002/cncr.30615

A high-resolution copy-number variation resource for clinical and population genetics

M. Uddin, B. Thiruvahindrapuram, S. Walker, et al.. (2014). Genetics in Medicine. Cited 79 times. https://doi.org/10.1038/gim.2014.178

Prognosis of premenopausal breast cancer and childbirth prior to diagnosis.

K. Phillips, R. Milne, M. Friedlander, et al.. (2004). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 79 times. https://doi.org/10.1200/JCO.2004.07.062

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.

A. Spurdle, J. Hopper, G. Dite, et al.. (2000). Journal of the National Cancer Institute. Cited 79 times. https://doi.org/10.1093/JNCI/92.20.1674

Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies

I. Roland, Wan-lin Yang, Dong-Hua Yang, et al.. (2003). Cancer. Cited 78 times. https://doi.org/10.1002/cncr.11847

Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry

A. Kurian, G. Gong, E. John, et al.. (2009). Cancer Epidemiology Biomarkers & Prevention. Cited 77 times. https://doi.org/10.1158/1055-9965.EPI-08-1090

Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk.

Xiaowei Chen, J. Weaver, B. Bove, et al.. (2008). Human molecular genetics. Cited 77 times. https://doi.org/10.1093/hmg/ddn022

Putting the risk of breast cancer in perspective.

K. Phillips, G. Glendon, J. A. Knight. (1999). The New England journal of medicine. Cited 77 times. https://doi.org/10.1056/NEJM199901143400211

Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry.

D. Huo, Yonglan Zheng, T. Ogundiran, et al.. (2012). Carcinogenesis. Cited 76 times. https://doi.org/10.1093/carcin/bgs093

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

M. Ghoussaini, J. French, K. Michailidou, et al.. (2016). American Journal of Human Genetics. Cited 74 times. https://doi.org/10.1016/j.ajhg.2016.07.017

40 Years of Change in Age- and Stage-Specific Cancer Incidence Rates in US Women and Men

Rebecca D. Kehm, Wan Yang, P. Tehranifar, et al.. (2019). JNCI Cancer Spectrum. Cited 74 times. https://doi.org/10.1093/jncics/pkz038

Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture.

G. Bhatia, G. Bhatia, Arti Tandon, et al.. (2014). American journal of human genetics. Cited 73 times. https://doi.org/10.1016/j.ajhg.2014.08.011

Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study.

M. McCredie, G. Dite, L. Porter, et al.. (2001). Breast. Cited 73 times. https://doi.org/10.1054/BRST.2000.0291

Cost‐effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry

R. Manchanda, Shreeya Patel, A. Antoniou, et al.. (2017). American Journal of Obstetrics and Gynecology. Cited 72 times. https://doi.org/10.1016/j.ajog.2017.06.038

Medical radiation exposure and breast cancer risk: Findings from the Breast Cancer Family Registry

E. John, A. Phipps, J. Knight, et al.. (2007). International Journal of Cancer. Cited 72 times. https://doi.org/10.1002/ijc.22668

Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study

J. Figueiredo, M. Ennis, J. Knight, et al.. (2007). Breast Cancer Research and Treatment. Cited 71 times. https://doi.org/10.1007/s10549-006-9433-3

Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry.

Richard H. Osborne, G. Elsworth, John L. Hopper. (2003). European journal of cancer. Cited 71 times. https://doi.org/10.1016/S0959-8049(02)00814-6

Genetic epidemiology of female breast cancer.

John L. Hopper. (2001). Seminars in cancer biology. Cited 71 times. https://doi.org/10.1006/SCBI.2001.0392

Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.

L. Fejerman, Gary K. Chen, C. Eng, et al.. (2012). Human molecular genetics. Cited 70 times. https://doi.org/10.1093/hmg/ddr617

Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women.

V. Setiawan, L. Chu, E. John, et al.. (2008). Cancer genetics and cytogenetics. Cited 70 times. https://doi.org/10.1016/j.cancergencyto.2007.10.019

Reproductive history, breast‐feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study

E. John, Lisa M Hines, A. Phipps, et al.. (2018). International Journal of Cancer. Cited 69 times. https://doi.org/10.1002/ijc.31258

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

R. Milne, B. Burwinkel, K. Michailidou, et al.. (2014). Human Molecular Genetics. Cited 68 times. https://doi.org/10.1093/hmg/ddu311

Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.

Hui-Chen Wu, L. Delgado-Cruzata, J. Flom, et al.. (2012). Carcinogenesis. Cited 68 times. https://doi.org/10.1093/carcin/bgs201

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.

A. Spurdle, J. Hopper, Xiaoqing Chen, et al.. (2002). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 68 times.

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

S. Done, N. Arneson, H. Ozçelik, et al.. (1998). Cancer research. Cited 68 times.

A multicenter study of supportive‐expressive group therapy for women with BRCA1/BRCA2 mutations

M. Esplen, J. Hunter, M. Leszcz, et al.. (2004). Cancer. Cited 67 times. https://doi.org/10.1002/cncr.20661

Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry

Meghan E. Work, E. John, I. Andrulis, et al.. (2014). British Journal of Cancer. Cited 66 times. https://doi.org/10.1038/bjc.2013.807

Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans.

Fang Chen, Gary K. Chen, R. Millikan, et al.. (2011). Human molecular genetics. Cited 66 times. https://doi.org/10.1093/hmg/ddr367

AT-tributable risks?

D. Timothy Bishop, J. Hopper. (1997). Nature Genetics. Cited 66 times. https://doi.org/10.1038/NG0397-226

BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research

S. Neuhausen, H. Ozçelik, M. Southey, et al.. (2009). Breast Cancer Research and Treatment. Cited 65 times. https://doi.org/10.1007/s10549-008-0153-8

The Mental Adjustment to Cancer (MAC) Scale: replication and refinement in 632 breast cancer patients

Richard H. Osborne, G. Elsworth, David W. Kissane, et al.. (1999). Psychological Medicine. Cited 65 times. https://doi.org/10.1017/S0033291799001142

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

F. Couch, M. Gaudet, A. Antoniou, et al.. (2012). Cancer Epidemiology, Biomarkers & Prevention. Cited 64 times. https://doi.org/10.1158/1055-9965.EPI-11-0888

Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer

Jing Shen, Y. Liao, J. Hopper, et al.. (2017). British Journal of Cancer. Cited 63 times. https://doi.org/10.1038/bjc.2017.81

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

T. Rebbeck, T. Friebel, N. Mitra, et al.. (2016). Breast Cancer Research : BCR. Cited 63 times. https://doi.org/10.1186/s13058-016-0768-3

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Karoline B. Kuchenbaecker, S. Neuhausen, M. Robson, et al.. (2014). Breast Cancer Research : BCR. Cited 63 times. https://doi.org/10.1186/s13058-014-0492-9

Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.

T. Rebbeck, N. Mitra, S. Domchek, et al.. (2011). Cancer research. Cited 63 times. https://doi.org/10.1158/0008-5472.CAN-11-0773

iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management

Ian M. Collins, A. Bickerstaffe, Thilina Ranaweera, et al.. (2016). Breast Cancer Research and Treatment. Cited 62 times. https://doi.org/10.1007/s10549-016-3726-y

Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures.

J. Stone, Deborah J. Thompson, I. dos Santos Silva, et al.. (2015). Cancer research. Cited 62 times. https://doi.org/10.1158/0008-5472.CAN-14-2012

Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer.

L. Baglietto, K. Krishnan, J. Stone, et al.. (2014). American journal of epidemiology. Cited 62 times. https://doi.org/10.1093/aje/kwt260

Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the breast cancer family registry

T. Keegan, R. Milne, I. Andrulis, et al.. (2010). Breast Cancer Research and Treatment. Cited 61 times. https://doi.org/10.1007/s10549-010-0774-6

The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing

P. Pharoah, Rachel T. Palmieri, S. Ramus, et al.. (2011). Clinical Cancer Research. Cited 60 times. https://doi.org/10.1158/1078-0432.CCR-10-3405

Quality of cancer registry birthplace data for Hispanics living in the United States

S. Gomez, S. Glaser. (2005). Cancer Causes & Control. Cited 60 times. https://doi.org/10.1007/s10552-005-0694-7

Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

R. Hein, R. Hein, M. Maranian, et al.. (2012). PLoS ONE. Cited 59 times. https://doi.org/10.1371/journal.pone.0042380

Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families

Z. L. Teo, Daniel J. Park, E. Provenzano, et al.. (2013). Breast Cancer Research : BCR. Cited 58 times. https://doi.org/10.1186/bcr3392

Mammographic breast density and breast cancer: evidence of a shared genetic basis.

Jajini S Varghese, Deborah J. Thompson, K. Michailidou, et al.. (2012). Cancer research. Cited 58 times. https://doi.org/10.1158/0008-5472.CAN-11-3295

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

S. Ramus, Christiana Kartsonaki, S. Gayther, et al.. (2011). Journal of the National Cancer Institute. Cited 58 times. https://doi.org/10.1093/jnci/djq494

Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer

M. Sauer, I. Andrulis. (2005). Journal of Medical Genetics. Cited 58 times. https://doi.org/10.1136/jmg.2004.030049

Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple‐case breast cancer families

A. Tesoriero, E. M. Wong, M. Jenkins, et al.. (2005). Human Mutation. Cited 58 times. https://doi.org/10.1002/humu.9379

HER‐2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

Louise A. Quenneville, K. Phillips, H. Ozçelik, et al.. (2002). Cancer. Cited 58 times. https://doi.org/10.1002/cncr.10949

Genetic predisposition to ductal carcinoma in situ of the breast

C. Petridis, M. Brook, Vandna Shah, et al.. (2016). Breast Cancer Research : BCR. Cited 57 times. https://doi.org/10.1186/s13058-016-0675-7

DNA mismatch repair gene MSH6 implicated in determining age at natural menopause

J. Perry, Y. Hsu, D. Chasman, et al.. (2013). Human Molecular Genetics. Cited 57 times. https://doi.org/10.1093/hmg/ddt620

Genome-wide association study of age at menarche in African-American women.

E. Demerath, Ching‐Ti Liu, N. Franceschini, et al.. (2013). Human molecular genetics. Cited 57 times. https://doi.org/10.1093/hmg/ddt181

Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue

S. Lin, J. Cawson, P. Hill, et al.. (2011). Breast Cancer Research and Treatment. Cited 57 times. https://doi.org/10.1007/s10549-011-1346-0

Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies.

Jeanne C. Beck, Christine M. Beiswanger, Esther M. John, et al.. (2001). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 57 times.

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

Hongyan Li, B. Feng, A. Miron, et al.. (2016). Genetics in medicine : official journal of the American College of Medical Genetics. Cited 56 times. https://doi.org/10.1038/gim.2016.43

Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR‐103 target site

Brooke L. Brewster, F. Rossiello, J. French, et al.. (2012). Human Mutation. Cited 56 times. https://doi.org/10.1002/humu.22159

Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors

A. Bane, Dushanthi Pinnaduwage, Sarah Colby, et al.. (2008). Breast Cancer Research and Treatment. Cited 56 times. https://doi.org/10.1007/s10549-008-0087-1

An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers

Jordana Segal, M. Esplen, B. Toner, et al.. (2004). American Journal of Medical Genetics Part A. Cited 56 times. https://doi.org/10.1002/ajmg.a.20485

Detection of disease genes by use of family data. I. Likelihood-based theory.

A. Whittemore, I. Tu. (2000). American journal of human genetics. Cited 56 times. https://doi.org/10.1086/302851

Body mass index and breast cancer survival: a Mendelian randomization analysis

Qi Guo, S. Burgess, Constance Turman, et al.. (2017). International Journal of Epidemiology. Cited 54 times. https://doi.org/10.1093/ije/dyx131

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

A. Gusev, Huwenbo Shi, Gleb Kichaev, et al.. (2016). Nature Communications. Cited 54 times. https://doi.org/10.1038/ncomms10979

Meta-analysis of loci associated with age at natural menopause in African-American women.

Christina T. L. Chen, Ching‐Ti Liu, Gary K. Chen, et al.. (2014). Human molecular genetics. Cited 54 times. https://doi.org/10.1093/hmg/ddu041

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers

S. Neuhausen, S. Brummel, Y. Ding, et al.. (2009). Breast Cancer Research : BCR. Cited 54 times. https://doi.org/10.1186/bcr2414

The CHEK2*1100delC Allelic Variant and Risk of Breast Cancer: Screening Results from the Breast Cancer Family Registry

J. Bernstein, S. Teraoka, E. John, et al.. (2006). Cancer Epidemiology Biomarkers & Prevention. Cited 54 times. https://doi.org/10.1158/1055-9965.EPI-05-0557

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics

C. Scott, M. Jenkins, M. Southey, et al.. (2003). Human Genetics. Cited 54 times. https://doi.org/10.1007/s00439-003-0908-6

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2

K. Phillips, E. Warner, W. Meschino, et al.. (2000). Clinical Genetics. Cited 54 times. https://doi.org/10.1034/j.1399-0004.2000.570508.x

Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

E. Sawyer, R. Roylance, C. Petridis, et al.. (2014). Cited 53 times. https://doi.org/10.1371/journal.pgen.1004285

Neighborhood influences on recreational physical activity and survival after breast cancer

T. Keegan, Salma Shariff-Marco, Meera Sangaramoorthy, et al.. (2014). Cancer Causes & Control. Cited 53 times. https://doi.org/10.1007/s10552-014-0431-1

Decision Making with Uncertain Information: Learning from Women in a High Risk Breast Cancer Clinic

Caren J. Frost, V. Venne, D. Cunningham, et al.. (2004). Journal of Genetic Counseling. Cited 53 times. https://doi.org/10.1023/B:JOGC.0000027958.02383.a9

Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.

Daniel J. Park, K. Tao, F. Calvez-Kelm, et al.. (2014). Cancer discovery. Cited 52 times. https://doi.org/10.1158/2159-8290.CD-14-0212

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach

M. Tischkowitz, N. Hamel, Marcelo A. Carvalho, et al.. (2008). European Journal of Human Genetics. Cited 52 times. https://doi.org/10.1038/ejhg.2008.13

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

A. Spurdle, A. Antoniou, D. Duffy, et al.. (2004). Breast Cancer Research. Cited 52 times. https://doi.org/10.1186/bcr971

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers

H. Özçelik, M. To, J. Couture, et al.. (1998). International Journal of Cancer. Cited 52 times. https://doi.org/10.1002/(SICI)1097-0215(19980703)77:1<1::AID-IJC1>3.0.CO;2-Y

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

J. Painter, T. O’Mara, J. Batra, et al.. (2014). Human Molecular Genetics. Cited 51 times. https://doi.org/10.1093/hmg/ddu552

UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms and Total Bilirubin Levels in an Ethnically Diverse Cohort of Women

A. Hong, D. Huo, Hee-Jin Kim, et al.. (2007). Drug Metabolism and Disposition. Cited 51 times. https://doi.org/10.1124/dmd.106.014183

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

N. Orr, F. Dudbridge, N. Dryden, et al.. (2015). Human Molecular Genetics. Cited 50 times. https://doi.org/10.1093/hmg/ddv035

A role for XRCC2 gene polymorphisms in breast cancer risk and survival

Wei-Yu Lin, N. Camp, L. Cannon-Albright, et al.. (2011). Journal of Medical Genetics. Cited 50 times. https://doi.org/10.1136/jmedgenet-2011-100018

Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States.

D. Huo, R. Senie, M. Daly, et al.. (2009). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 50 times. https://doi.org/10.1200/JCO.2008.17.5869

Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study

H. Ahsan, A. Whittemore, Yu Chen, et al.. (2004). Breast Cancer Research. Cited 50 times. https://doi.org/10.1186/bcr951

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

C. Phelan, K. Kuchenbaecker, J. Tyrer, et al.. (2017). Nature Genetics. Cited 49 times. https://doi.org/10.1038/ng.3826

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study

O. Brouckaert, A. Rudolph, A. Laenen, et al.. (2017). Breast Cancer Research : BCR. Cited 49 times. https://doi.org/10.1186/s13058-017-0909-3

Preventing breast and ovarian cancers in high‐risk BRCA1 and BRCA2 mutation carriers

I. Collins, R. Milne, P. Weideman, et al.. (2013). Medical Journal of Australia. Cited 49 times. https://doi.org/10.5694/mja13.10848

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.

D. Cox, J. Simard, D. Sinnett, et al.. (2011). Human molecular genetics. Cited 49 times. https://doi.org/10.1093/hmg/ddr388

Are ATM Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles?

C. Szabo, M. Schutte, A. Broeks, et al.. (2004). Cancer Research. Cited 49 times. https://doi.org/10.1158/0008-5472.CAN-03-2678

BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk

Annika Auranen, A. Spurdle, Xiaoqing Chen, et al.. (2003). International Journal of Cancer. Cited 49 times. https://doi.org/10.1002/ijc.10814

The Impact of Social Roles on the Experience of Men in BRCA1/2 Families: Implications for Counseling

M. Daly. (2009). Journal of Genetic Counseling. Cited 48 times. https://doi.org/10.1007/s10897-008-9183-y

Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies

S. Johnatty, A. Spurdle, J. Beesley, et al.. (2008). Breast Cancer Research and Treatment. Cited 47 times. https://doi.org/10.1007/s10549-007-9627-3

Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario

L. Briollais, Yuanyuan Wang, I. Rajendram, et al.. (2007). BMC Medicine. Cited 47 times. https://doi.org/10.1186/1741-7015-5-22

No Increased Risk of Breast Cancer Associated with Alcohol Consumption among Carriers of BRCA1 and BRCA2 Mutations Ages <50 Years

V. McGuire, E. John, Anna Felberg, et al.. (2006). Cancer Epidemiology Biomarkers & Prevention. Cited 47 times. https://doi.org/10.1158/1055-9965.EPI-06-0323

An Admixture Scan in 1,484 African American Women with Breast Cancer

L. Fejerman, C. Haiman, D. Reich, et al.. (2009). Cancer Epidemiology, Biomarkers & Prevention. Cited 46 times. https://doi.org/10.1158/1055-9965.EPI-09-0464

Description and validation of high‐throughput simultaneous genotyping and mutation scanning by high‐resolution melting curve analysis

T. Nguyen-Dumont, F. Calvez-Kelm, Nathalie Forey, et al.. (2009). Human Mutation. Cited 46 times. https://doi.org/10.1002/humu.20949

Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study

Rebecca D. Kehm, J. Hopper, E. John, et al.. (2019). Breast Cancer Research : BCR. Cited 46 times. https://doi.org/10.1186/s13058-019-1135-y

A functionally significant SNP in TP53 and breast cancer risk in African-American women

M. Murphy, Song Liu, S. Yao, et al.. (2017). NPJ Breast Cancer. Cited 45 times. https://doi.org/10.1038/s41523-017-0007-9

Racial/Ethnic Differences in the Impact of Neighborhood Social and Built Environment on Breast Cancer Risk: The Neighborhoods and Breast Cancer Study

S. M. Conroy, Salma Shariff-Marco, Jocelyn Koo, et al.. (2017). Cancer Epidemiology, Biomarkers & Prevention. Cited 45 times. https://doi.org/10.1158/1055-9965.EPI-16-0935

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

R. Milne, J. Herranz, K. Michailidou, et al.. (2014). Human molecular genetics. Cited 45 times. https://doi.org/10.1093/hmg/ddt581

Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model

G. Dite, M. Mahmoodi, A. Bickerstaffe, et al.. (2013). Breast Cancer Research and Treatment. Cited 45 times. https://doi.org/10.1007/s10549-013-2610-2

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

S. Ramus, A. Antoniou, Karoline B. Kuchenbaecker, et al.. (2012). Human Mutation. Cited 45 times. https://doi.org/10.1002/humu.22025

Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations

Jennifer S. Lee, E. John, V. McGuire, et al.. (2006). Cancer Epidemiology Biomarkers & Prevention. Cited 45 times. https://doi.org/10.1158/1055-9965.EPI-05-0687

Human SNPs resulting in premature stop codons and protein truncation

S. Savas, S. Tuzmen, H. Ozçelik. (2006). Human Genomics. Cited 45 times. https://doi.org/10.1186/1479-7364-2-5-274

Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study.

L. Keogh, M. Southey, J. Maskiell, et al.. (2004). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 45 times. https://doi.org/10.1158/1055-9965.2258.13.12

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)

C. Apicella, L. Andrews, S. Hodgson, et al.. (2003). Breast Cancer Research : BCR. Cited 45 times. https://doi.org/10.1186/bcr644

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status

M. McCredie, G. Dite, M. Southey, et al.. (2003). British Journal of Cancer. Cited 45 times. https://doi.org/10.1038/sj.bjc.6601293

The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.

K. Montgomery, D. Gertig, S. Baxter, et al.. (2003). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 45 times.

FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles.

D. Godler, H. Slater, Q. M. Bui, et al.. (2011). The Journal of molecular diagnostics : JMD. Cited 44 times. https://doi.org/10.1016/j.jmoldx.2011.05.006

Morphological predictors of BRCA1 germline mutations in young women with breast cancer

M. Southey, S. Ramus, J. Dowty, et al.. (2011). British Journal of Cancer. Cited 44 times. https://doi.org/10.1038/bjc.2011.41

Functional characterization of novel presenilin-2 variants identified in human breast cancers

Minh D. To, Minh D. To, Minh D. To, et al.. (2006). Oncogene. Cited 44 times. https://doi.org/10.1038/sj.onc.1209397

Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

Jiajun Shi, Yanfeng Zhang, W. Zheng, et al.. (2016). International Journal of Cancer. Cited 43 times. https://doi.org/10.1002/ijc.30150

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

Hatef Darabi, K. McCue, J. Beesley, et al.. (2015). American journal of human genetics. Cited 43 times. https://doi.org/10.1016/j.ajhg.2015.05.002

Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases

Alaa M Ali, M. Schmidt, M. Bolla, et al.. (2014). Cancer Epidemiology, Biomarkers & Prevention. Cited 43 times. https://doi.org/10.1158/1055-9965.EPI-13-0901

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre

R. MacInnis, R. MacInnis, A. Bickerstaffe, et al.. (2013). British Journal of Cancer. Cited 43 times. https://doi.org/10.1038/bjc.2013.382

A supportive–expressive group intervention for women with a family history of breast cancer: results of a phase II study

M. Esplen, B. Toner, J. Hunter, et al.. (2000). Psycho‐Oncology. Cited 43 times. https://doi.org/10.1002/1099-1611(200005/06)9:3<243::AID-PON457>3.0.CO;2-I

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

I. Blanco, Karoline B. Kuchenbaecker, D. Cuadras, et al.. (2015). PLoS ONE. Cited 42 times. https://doi.org/10.1371/journal.pone.0120020

Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry

L. Delgado-Cruzata, Hui-Chen Wu, M. Perrin, et al.. (2012). Epigenetics. Cited 42 times. https://doi.org/10.4161/epi.20830

New Strategies in Ovarian Cancer: Uptake and Experience of Women at High Risk of Ovarian Cancer Who Are Considering Risk-Reducing Salpingo-Oophorectomy

Suzanne M. Miller, P. Roussi, M. Daly, et al.. (2010). Clinical Cancer Research. Cited 42 times. https://doi.org/10.1158/1078-0432.CCR-09-2953

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

U. V. Onay, Kirsimari Aaltonen, L. Briollais, et al.. (2008). BMC Cancer. Cited 42 times. https://doi.org/10.1186/1471-2407-8-6

Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results

A. Bradbury, L. Patrick-Miller, D. Fetzer, et al.. (2011). Clinical Genetics. Cited 41 times. https://doi.org/10.1111/j.1399-0004.2010.01540.x

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

T. Rebbeck, N. Mitra, S. Domchek, et al.. (2009). Cancer research. Cited 41 times. https://doi.org/10.1158/0008-5472.CAN-09-0625

G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history

T. Anagnostopoulos, M. Pertesi, I. Konstantopoulou, et al.. (2008). Breast Cancer Research and Treatment. Cited 41 times. https://doi.org/10.1007/s10549-007-9729-y

A Systematic Approach to Analysing Gene-Gene Interactions: Polymorphisms at the Microsomal Epoxide Hydrolase EPHX and Glutathione S-transferase GSTM1, GSTT1, and GSTP1 Loci and Breast Cancer Risk

A. Spurdle, Jiun-Horng Chang, G. Byrnes, et al.. (2007). Cancer Epidemiology Biomarkers & Prevention. Cited 41 times. https://doi.org/10.1158/1055-9965.EPI-06-0776

Problems in the definition, interpretation, and evaluation of genetic heterogeneity.

A. Whittemore, J. Halpern. (2001). American journal of human genetics. Cited 41 times. https://doi.org/10.1086/318186

Implications of a novel cryptic splice site in the BRCA1 gene.

J. Hoffman, S. Hallam, V. Venne, et al.. (1998). American journal of medical genetics. Cited 41 times. https://doi.org/10.1002/(SICI)1096-8628(19981102)80:2<140::AID-AJMG10>3.0.CO;2-L

Longitudinal Study of Mammographic Density Measures That Predict Breast Cancer Risk

K. Krishnan, L. Baglietto, J. Stone, et al.. (2017). Cancer Epidemiology, Biomarkers & Prevention. Cited 40 times. https://doi.org/10.1158/1055-9965.EPI-16-0499

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

Y. Hamdi, P. Soucy, Véronique Adoue, et al.. (2016). Oncotarget. Cited 40 times. https://doi.org/10.18632/oncotarget.12818

Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

A. Rudolph, R. Milne, Thérèse Truong, et al.. (2015). International Journal of Cancer. Cited 40 times. https://doi.org/10.1002/ijc.29188

Explaining Variance in the Cumulus Mammographic Measures That Predict Breast Cancer Risk: A Twins and Sisters Study

T. Nguyen, Daniel F. Schmidt, E. Makalic, et al.. (2013). Cancer Epidemiology, Biomarkers & Prevention. Cited 40 times. https://doi.org/10.1158/1055-9965.EPI-13-0481

11q13 is a susceptibility locus for hormone receptor positive breast cancer

D. Lambrechts, Thérèse Truong, C. Justenhoven, et al.. (2012). Human Mutation. Cited 40 times. https://doi.org/10.1002/humu.22089

Global DNA methylation levels in girls with and without a family history of breast cancer

Hui-Chen Wu, E. John, J. Ferris, et al.. (2011). Epigenetics. Cited 40 times. https://doi.org/10.4161/epi.6.1.13393

AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study

F. Couch, O. Sinilnikova, R. Vierkant, et al.. (2007). Cancer Epidemiology Biomarkers & Prevention. Cited 40 times. https://doi.org/10.1158/1055-9965.EPI-07-0129

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

J. Weitzel, S. Buys, W. Sherman, et al.. (2007). Clinical Cancer Research. Cited 40 times. https://doi.org/10.1158/1078-0432.CCR-06-1902

A Family-based Genetic Association Study of Variants in Estrogen-metabolism Genes COMT and CYP1B1 and Breast Cancer Risk

H. Ahsan, Yu Chen, A. Whittemore, et al.. (2004). Breast Cancer Research and Treatment. Cited 40 times. https://doi.org/10.1023/B:BREA.0000025401.60794.68

Analysis of mRNA from microdissected frozen tissue sections without RNA isolation.

M. To, S. Done, M. Redston, et al.. (1998). The American journal of pathology. Cited 40 times. https://doi.org/10.1016/S0002-9440(10)65544-7

Tests for genetic association using family data

M. Shih, A. Whittemore. (2002). Genetic Epidemiology. Cited 39 times. https://doi.org/10.1002/GEPI.0151

Genetic ancestry and risk of mortality among U.S. Latinas with breast cancer.

L. Fejerman, D. Hu, S. Huntsman, et al.. (2013). Cancer research. Cited 38 times. https://doi.org/10.1158/0008-5472.CAN-13-2014

Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR.

N. Machella, M. Terry, J. Zipprich, et al.. (2008). Carcinogenesis. Cited 38 times. https://doi.org/10.1093/carcin/bgn140

Quality of birthplace information obtained from death certificates for Hispanics, Asians, and Pacific Islanders.

S. Gomez, S. Glaser. (2004). Ethnicity & disease. Cited 38 times.

Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies.

J. Knight, H. Sutherland, G. Glendon, et al.. (2002). Annals of epidemiology. Cited 38 times. https://doi.org/10.1016/S1047-2797(01)00253-8

Studying cancer incidence and outcomes in immigrants: methodological concerns.

Scarlett S. Lin, C. Clarke, C. O’Malley, et al.. (2002). American journal of public health. Cited 38 times. https://doi.org/10.2105/AJPH.92.11.1757-A

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

Asaf Wyszynski, C. Hong, K. Lam, et al.. (2016). Human molecular genetics. Cited 37 times. https://doi.org/10.1093/hmg/ddw223

Practical Problems With Clinical Guidelines for Breast Cancer Prevention Based on Remaining Lifetime Risk

A. Quante, A. Whittemore, Tom Shriver, et al.. (2015). JNCI Journal of the National Cancer Institute. Cited 37 times. https://doi.org/10.1093/jnci/djv124

A comprehensive examination of breast cancer risk loci in African American women.

Ye Feng, D. Stram, S. Rhie, et al.. (2014). Human molecular genetics. Cited 37 times. https://doi.org/10.1093/hmg/ddu252

Identification of a novel percent mammographic density locus at 12q24.

Kristen Stevens, S. Lindstrom, C. Scott, et al.. (2012). Human molecular genetics. Cited 37 times. https://doi.org/10.1093/hmg/dds158

Prediagnosis Reproductive Factors and All-Cause Mortality for Women with Breast Cancer in the Breast Cancer Family Registry

K. Phillips, R. Milne, D. West, et al.. (2009). Cancer Epidemiology Biomarkers & Prevention. Cited 37 times. https://doi.org/10.1158/1055-9965.EPI-08-1014

Collective Fear, Individualized Risk: the social and cultural context of genetic testing forbreast cancer

N. Press, J. Fishman, Barbara A. Koenig. (2000). Nursing Ethics. Cited 37 times. https://doi.org/10.1177/096973300000700306

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

F. Qian, Shengfeng Wang, Jonathan A. Mitchell, et al.. (2018). Journal of the National Cancer Institute. Cited 37 times. https://doi.org/10.1093/jnci/djy132

Multigene testing of moderate-risk genes: be mindful of the missense

E. Young, Bing Jian Feng, A. Stark, et al.. (2016). Journal of Medical Genetics. Cited 36 times. https://doi.org/10.1136/jmedgenet-2015-103398

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry

T. Menes, M. Terry, D. Goldgar, et al.. (2015). Breast Cancer Research and Treatment. Cited 36 times. https://doi.org/10.1007/s10549-015-3419-y

No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family Study

Daniel J. Park, M. Southey, G. Giles, et al.. (2010). Breast Cancer Research and Treatment. Cited 36 times. https://doi.org/10.1007/s10549-010-0946-4

Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions

Anja Schoeps, A. Rudolph, P. Seibold, et al.. (2014). Genetic Epidemiology. Cited 35 times. https://doi.org/10.1002/gepi.21771

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

A. Jakubowska, D. Rozkrut, A. Antoniou, et al.. (2012). British Journal of Cancer. Cited 35 times. https://doi.org/10.1038/bjc.2012.160

RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study

F. Le Calvez-Kelm, J. Oliver, F. Damiola, et al.. (2012). PLoS ONE. Cited 35 times. https://doi.org/10.1371/journal.pone.0052374

Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.

J. Zipprich, M. Terry, Y. Liao, et al.. (2009). Cancer research. Cited 35 times. https://doi.org/10.1158/0008-5472.CAN-08-3418

Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years

A. Whittemore, E. John, Anna Felberg, et al.. (2008). Breast Cancer Research and Treatment. Cited 35 times. https://doi.org/10.1007/s10549-007-9621-9

Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans

D. Huo, Hee-Jin Kim, C. Adebamowo, et al.. (2008). Breast Cancer Research and Treatment. Cited 35 times. https://doi.org/10.1007/s10549-007-9720-7

The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors

S. Winter, L. Bosnoyan-Collins, Dushanthi Pinnaduwage, et al.. (2007). BMC Cancer. Cited 35 times. https://doi.org/10.1186/1471-2407-7-85

A qualitative study of subject recruitment for familial cancer research.

Nancy Kreiger, Fredrick D. Ashbury, M. Cotterchio, et al.. (2001). Annals of epidemiology. Cited 35 times. https://doi.org/10.1016/S1047-2797(00)00221-0

Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation

H. Ozçelik, Yael Antebi, D. E. Cole, et al.. (1996). Human Genetics. Cited 35 times. https://doi.org/10.1007/s004390050212

Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

L. Walker, L. Marquart, J. Pearson, et al.. (2017). European Journal of Human Genetics. Cited 34 times. https://doi.org/10.1038/ejhg.2016.203

Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

L. Carvajal-Carmona, T. O’Mara, J. Painter, et al.. (2014). Human Genetics. Cited 34 times. https://doi.org/10.1007/s00439-014-1515-4

Aberrant Methylation of RASSF1A in Plasma DNA Before Breast Cancer Diagnosis in the Breast Cancer Family Registry

H. Yazici, M. Terry, Y. Cho, et al.. (2009). Cancer Epidemiology, Biomarkers & Prevention. Cited 34 times. https://doi.org/10.1158/1055-9965.EPI-08-1237

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study

Jiun-Horng Chang, D. Gertig, Xiaoqing Chen, et al.. (2005). Breast Cancer Research. Cited 34 times. https://doi.org/10.1186/bcr1040

Allele-sharing among affected relatives: non-parametric methods for identifying genes

M. Shih, A. Whittemore. (2001). Statistical Methods in Medical Research. Cited 34 times. https://doi.org/10.1177/096228020101000103

Detection of disease genes by use of family data. II. Application to nuclear families.

I-Ping Tu, Raymond R. Balise, Alice S. Whittemore. (2000). American journal of human genetics. Cited 34 times. https://doi.org/10.1086/302852

Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.

E. Warner, R. Heisey, V. Goel, et al.. (1999). Canadian family physician Medecin de famille canadien. Cited 34 times.

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

S. Blein, C. Bardel, Vincent Danjean, et al.. (2015). Breast Cancer Research : BCR. Cited 33 times. https://doi.org/10.1186/s13058-015-0567-2

Common germline polymorphisms associated with breast cancer-specific survival

A. Pirie, Qi Guo, P. Kraft, et al.. (2015). Breast Cancer Research : BCR. Cited 33 times. https://doi.org/10.1186/s13058-015-0570-7

microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.

Chine-Wen Chang, Hui-Chen Wu, M. Terry, et al.. (2015). Anticancer research. Cited 33 times.

Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

R. Milne, E. Goode, M. García-Closas, et al.. (2011). Cancer Epidemiology, Biomarkers & Prevention. Cited 33 times. https://doi.org/10.1158/1055-9965.EPI-11-0569

A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services

S. Peacock, C. Apicella, L. Andrews, et al.. (2006). British Journal of Cancer. Cited 33 times. https://doi.org/10.1038/sj.bjc.6603451

DNA adducts, DNA repair genotype/phenotype and cancer risk.

R. Santella, M. Gammon, M. Terry, et al.. (2005). Mutation research. Cited 33 times. https://doi.org/10.1016/J.MRFMMM.2005.06.001

DNA array‐based method for detection of large rearrangements in the BRCA1 gene

A. Frolov, A. Prowse, L. Vanderveer, et al.. (2002). Genes. Cited 33 times. https://doi.org/10.1002/gcc.10109

Development of a knowledge scale about breast cancer and heredity (BCHK)

N. Ondrusek, E. Warner, V. Goel. (2004). Breast Cancer Research and Treatment. Cited 33 times. https://doi.org/10.1023/A:1006114710328

The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

M. Terry, Y. Liao, K. Kast, et al.. (2018). JNCI Cancer Spectrum. Cited 33 times. https://doi.org/10.1093/jncics/pky078

Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry

F. Qian, Ye Feng, Yonglan Zheng, et al.. (2016). Human Genetics. Cited 32 times. https://doi.org/10.1007/s00439-016-1707-1

Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk

Xingyi Guo, J. Long, Chenjie Zeng, et al.. (2015). Cancer Epidemiology, Biomarkers & Prevention. Cited 32 times. https://doi.org/10.1158/1055-9965.EPI-15-0363

Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.

Yonglan Zheng, T. Ogundiran, A. Falusi, et al.. (2013). Carcinogenesis. Cited 32 times. https://doi.org/10.1093/carcin/bgt090

Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry

Li Rita Zhang, A. Chiarelli, G. Glendon, et al.. (2011). European Journal of Cancer Prevention. Cited 32 times. https://doi.org/10.1097/CEJ.0b013e3283447467

Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.

Maria Argos, M. Kibriya, F. Jasmine, et al.. (2008). Cancer genetics and cytogenetics. Cited 32 times. https://doi.org/10.1016/j.cancergencyto.2008.01.001

Phosphorylation states of cell cycle and DNA repair proteins can be altered by the nsSNPs

S. Savas, H. Ozçelik. (2005). BMC Cancer. Cited 32 times. https://doi.org/10.1186/1471-2407-5-107

Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR.

P. Chan, B. Wong, H. Ozçelik, et al.. (1999). Clinical chemistry. Cited 32 times. https://doi.org/10.1093/clinchem/45.8.1285

Worry Is Good for Breast Cancer Screening: A Study of Female Relatives from the Ontario Site of the Breast Cancer Family Registry

Li Rita Zhang, A. Chiarelli, G. Glendon, et al.. (2012). Journal of Cancer Epidemiology. Cited 31 times. https://doi.org/10.1155/2012/545062

Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations

G. Dite, A. Whittemore, J. Knight, et al.. (2010). British Journal of Cancer. Cited 31 times. https://doi.org/10.1038/sj.bjc.6605876

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis

Jane C. Figueiredo, Jane C. Figueiredo, Julia A. Knight, et al.. (2007). BMC Cancer. Cited 31 times. https://doi.org/10.1186/1471-2407-7-99

Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry

T. Nguyen-Dumont, F. Hammet, M. Mahmoodi, et al.. (2015). Breast Cancer Research and Treatment. Cited 30 times. https://doi.org/10.1007/s10549-014-3260-8

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

N. Johnson, F. Dudbridge, N. Orr, et al.. (2014). Breast Cancer Research : BCR. Cited 30 times. https://doi.org/10.1186/bcr3662

Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population‐based study

E. Provenzano, J. Hopper, G. Giles, et al.. (2004). Pathology. Cited 30 times. https://doi.org/10.1080/00313020410001692558

Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

P. Peterlongo, J. Chang-Claude, K. Moysich, et al.. (2014). Cancer Epidemiology, Biomarkers & Prevention. Cited 29 times. https://doi.org/10.1158/1055-9965.EPI-14-0532

A pilot genome-wide association study of early-onset breast cancer

M. Kibriya, F. Jasmine, Maria Argos, et al.. (2009). Breast Cancer Research and Treatment. Cited 29 times. https://doi.org/10.1007/s10549-008-0039-9

The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

A. Spurdle, A. Antoniou, L. Kelemen, et al.. (2006). Cancer Epidemiology Biomarkers & Prevention. Cited 29 times. https://doi.org/10.1158/1055-9965.EPI-05-0709

Logistic regression of family data from retrospective study designs

A. Whittemore, J. Halpern. (2003). Genetic Epidemiology. Cited 29 times. https://doi.org/10.1002/GEPI.10267

Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk

T. Nguyen, Y. K. Aung, Christopher F. Evans, et al.. (2016). International Journal of Epidemiology. Cited 28 times. https://doi.org/10.1093/ije/dyw212

Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation

Erica S. Rinella, Y. Shao, L. Yackowski, et al.. (2013). Human Genetics. Cited 28 times. https://doi.org/10.1007/s00439-013-1269-4

Decreased Prostate Cancer-Specific Survival of Men with BRCA2 Mutations from Multiple Breast Cancer Families

H. Thorne, A. Willems, E. Niedermayr, et al.. (2011). Cancer Prevention Research. Cited 28 times. https://doi.org/10.1158/1940-6207.CAPR-10-0397

Pancreatic Cancer Surveillance Among High-Risk Populations: Knowledge and Intent

Zoe Lewis, Caren J. Frost, V. Venne. (2009). Journal of Genetic Counseling. Cited 28 times. https://doi.org/10.1007/s10897-008-9205-9

Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent

C. Garner, Y. Ding, E. John, et al.. (2008). Human Genetics. Cited 28 times. https://doi.org/10.1007/s00439-008-0468-x

BRCA phenocopies or ascertainment bias?

D. Goldgar, V. Venne, T. Conner, et al.. (2007). Journal of medical genetics. Cited 28 times.

Common Polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not Associated with Breast Cancer Risk

B. Kuschel, G. Chenevix-Trench, A. Spurdle, et al.. (2005). Cancer Epidemiology Biomarkers & Prevention. Cited 28 times. https://doi.org/10.1158/1055-9965.EPI-04-0807

Identification of a splice acceptor site mutation in p16INK4A/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred

A. Prowse, David C. Schultz, S. Guo, et al.. (2003). Journal of Medical Genetics. Cited 28 times. https://doi.org/10.1136/jmg.40.8.e102

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

Prohibitin 3′ untranslated region polymorphism and breast cancer risk in Australian women

A. Spurdle, J. Hopper, Xiaoqing Chen, et al.. (2002). The Lancet. Cited 28 times. https://doi.org/10.1016/S0140-6736(02)11043-9

A Group Therapy Approach to Facilitate Integration of Risk Information for Women at Risk for Breast Cancer

M. Esplen, Brendan Toner, J. Hunter, et al.. (1998). The Canadian Journal of Psychiatry. Cited 28 times. https://doi.org/10.1177/070674379804300405

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

Zhiguo Zhao, W. Wen, K. Michailidou, et al.. (2016). Cancer Causes & Control. Cited 27 times. https://doi.org/10.1007/s10552-016-0741-6

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

K. Rand, C. Song, Eric Déan, et al.. (2016). Cancer Epidemiology, Biomarkers & Prevention. Cited 27 times. https://doi.org/10.1158/1055-9965.EPI-15-1193

Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry.

Maya Kappil, M. Terry, L. Delgado-Cruzata, et al.. (2016). Anticancer research. Cited 27 times. https://doi.org/10.21873/ANTICANRES.10987

DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry.

Maya Kappil, Y. Liao, M. Terry, et al.. (2016). Anticancer research. Cited 27 times.

Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters.

P. Tehranifar, Hui-Chen Wu, Tom Shriver, et al.. (2015). American journal of epidemiology. Cited 27 times. https://doi.org/10.1093/aje/kwu258

Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry

E. Chang, R. Milne, K. Phillips, et al.. (2009). Breast Cancer Research and Treatment. Cited 27 times. https://doi.org/10.1007/s10549-008-0255-3

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

A. Osorio, R. Milne, G. Pita, et al.. (2009). British Journal of Cancer. Cited 27 times. https://doi.org/10.1038/sj.bjc.6605416

Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry

M. Terry, J. Knight, L. Zablotska, et al.. (2007). Breast Cancer Research and Treatment. Cited 27 times. https://doi.org/10.1007/s10549-007-9498-7

Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium

Myrto Barrdahl, A. Rudolph, J. Hopper, et al.. (2017). International Journal of Cancer. Cited 26 times. https://doi.org/10.1002/ijc.30859

Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women

L. Kadalayil, Sofia Khan, H. Nevanlinna, et al.. (2017). Nature Communications. Cited 26 times. https://doi.org/10.1038/s41467-017-01775-y

Whole-Genome Amplification Enables Accurate Genotyping for Microarray-Based High-Density Single Nucleotide Polymorphism Array

F. Jasmine, H. Ahsan, I. Andrulis, et al.. (2008). Cancer Epidemiology Biomarkers & Prevention. Cited 26 times. https://doi.org/10.1158/1055-9965.EPI-08-0482

Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy

S. Shiau, R. Strehlau, Shuang Wang, et al.. (2019). Scientific Reports. Cited 26 times. https://doi.org/10.1038/s41598-019-46930-1

Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information

Deborah O. Himes, M. Clayton, G. Donaldson, et al.. (2015). Journal of Genetic Counseling. Cited 25 times. https://doi.org/10.1007/s10897-015-9866-0

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density

A. Rudolph, P. Fasching, S. Behrens, et al.. (2015). Breast Cancer Research : BCR. Cited 25 times. https://doi.org/10.1186/s13058-015-0625-9

A Genome-Wide Scan for Breast Cancer Risk Haplotypes among African American Women

C. Song, Gary K. Chen, R. Millikan, et al.. (2013). PLoS ONE. Cited 25 times. https://doi.org/10.1371/journal.pone.0057298

Diagnostic Chest X-Rays and Breast Cancer Risk before Age 50 Years for BRCA1 and BRCA2 Mutation Carriers

E. John, V. McGuire, Duncan C. Thomas, et al.. (2013). Cancer Epidemiology, Biomarkers & Prevention. Cited 25 times. https://doi.org/10.1158/1055-9965.EPI-13-0189

The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry.

R. Milne, E. John, J. Knight, et al.. (2011). International journal of epidemiology. Cited 25 times. https://doi.org/10.1093/ije/dyr110

Regressive logistic and proportional hazards disease models for within‐family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer

J. Cui, A. Spurdle, M. Southey, et al.. (2003). Genetic Epidemiology. Cited 25 times. https://doi.org/10.1002/gepi.10222

Optimal designs for estimating penetrance of rare mutations of a disease‐susceptibility gene

G. Gong, A. Whittemore. (2003). Genetic Epidemiology. Cited 25 times. https://doi.org/10.1002/gepi.10219

Removal of benzo(a)pyrene diol epoxide (BPDE)‐DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer

G. Motykiewicz, B. Faraglia, Lianwen Wang, et al.. (2002). Environmental and Molecular Mutagenesis. Cited 25 times. https://doi.org/10.1002/em.10095

Management of familial breast cancer risk

P. Goodwin. (2000). Breast Cancer Research and Treatment. Cited 25 times. https://doi.org/10.1023/A:1006470206271

Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry

Ye Feng, S. Rhie, D. Huo, et al.. (2017). Cancer Epidemiology, Biomarkers & Prevention. Cited 24 times. https://doi.org/10.1158/1055-9965.EPI-16-0567

The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry

A. Cloud, Ashley T. Thai, Y. Liao, et al.. (2015). Breast Cancer Research and Treatment. Cited 24 times. https://doi.org/10.1007/s10549-014-3234-x

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

D. Agarwal, D. Agarwal, S. Pineda, et al.. (2014). British Journal of Cancer. Cited 24 times. https://doi.org/10.1038/bjc.2013.769

Differences in DNA methylation by extent of breast cancer family history in unaffected women

L. Delgado-Cruzata, Hui-Chen Wu, Y. Liao, et al.. (2014). Epigenetics. Cited 24 times. https://doi.org/10.4161/epi.26880

Tumour morphology predicts PALB2 germline mutation status

Z. L. Teo, E. Provenzano, G. Dite, et al.. (2013). British Journal of Cancer. Cited 24 times. https://doi.org/10.1038/bjc.2013.295

A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

L. McGuffog, S. Healey, E. Friedman, et al.. (2012). Cancer Epidemiology, Biomarkers & Prevention. Cited 24 times. https://doi.org/10.1158/1055-9965.EPI-12-0229

Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry.

A. Kurian, G. Gong, E. John, et al.. (2011). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 24 times. https://doi.org/10.1200/JCO.2010.34.4440

FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer

Daniel J. Park, F. Odefrey, F. Hammet, et al.. (2011). Breast Cancer Research and Treatment. Cited 24 times. https://doi.org/10.1007/s10549-011-1704-y

Admixture Mapping of African–American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes

E. Ruiz-Narváez, Lara E Sucheston-Campbell, J. Bensen, et al.. (2016). Frontiers in Genetics. Cited 23 times. https://doi.org/10.3389/fgene.2016.00170

Impact of neighborhoods and body size on survival after breast cancer diagnosis.

Salma Shariff-Marco, S. Gomez, Meera Sangaramoorthy, et al.. (2015). Health & place. Cited 23 times. https://doi.org/10.1016/j.healthplace.2015.10.003

Genomic Methylation Changes Over Time in Peripheral Blood Mononuclear Cell DNA: Differences by Assay Type and Baseline Values

Hui-Chen Wu, Qiao Wang, L. Delgado-Cruzata, et al.. (2012). Cancer Epidemiology, Biomarkers & Prevention. Cited 23 times. https://doi.org/10.1158/1055-9965.EPI-12-0300

BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study.

Letitia D. Smith, A. Tesoriero, S. Ramus, et al.. (2007). European journal of cancer. Cited 23 times. https://doi.org/10.1016/J.EJCA.2007.01.011

The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.

A. Spurdle, J. Hopper, Xiaoqing Chen, et al.. (2001). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 23 times.

The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario.

H. Sutherland, J. Lacroix, J. Knight, et al.. (2001). Journal of clinical epidemiology. Cited 23 times. https://doi.org/10.1016/S0895-4356(00)00263-8

The APCI1307K allele and breast cancer risk.

M. Redston, K. Nathanson, Z. Yuan, et al.. (1998). Nature genetics. Cited 23 times.

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

Y. Hamdi, P. Soucy, Karoline Kuchenbaeker, et al.. (2016). Breast Cancer Research and Treatment. Cited 22 times. https://doi.org/10.1007/s10549-016-4018-2

The LEGACY Girls Study: Growth and Development in the Context of Breast Cancer Family History

E. John, M. Terry, T. Keegan, et al.. (2016). Epidemiology. Cited 22 times. https://doi.org/10.1097/EDE.0000000000000456

Accuracy of Self-Reported Breast Cancer Information among Women from the Ontario Site of the Breast Cancer Family Registry

A. Barisic, G. Glendon, Nayana Weerasooriya, et al.. (2012). Journal of Cancer Epidemiology. Cited 22 times. https://doi.org/10.1155/2012/310804

9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

H. Warren, F. Dudbridge, O. Fletcher, et al.. (2012). Cancer Epidemiology, Biomarkers & Prevention. Cited 22 times. https://doi.org/10.1158/1055-9965.EPI-12-0526

The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis

S. Johnatty, J. Beesley, Xiaoqing Chen, et al.. (2009). Breast Cancer Research and Treatment. Cited 22 times. https://doi.org/10.1007/s10549-008-0045-y

Classifying disease chromosomes arising from multiple founders, with application to fine‐scale haplotype mapping

K. Yu, R. Martin, A. Whittemore. (2004). Genetic Epidemiology. Cited 22 times. https://doi.org/10.1002/gepi.20016

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

J. Lei, A. Rudolph, K. Moysich, et al.. (2015). Breast Cancer Research : BCR. Cited 21 times. https://doi.org/10.1186/s13058-015-0522-2

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families

S. Harvey, R. Milne, S. McLachlan, et al.. (2011). Breast Cancer Research and Treatment. Cited 21 times. https://doi.org/10.1007/s10549-011-1733-6

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

K. Im, T. Kirchhoff, Xianshu Wang, et al.. (2011). Human Genetics. Cited 21 times. https://doi.org/10.1007/s00439-011-1003-z

Exploring the link between MORF4L1 and risk of breast cancer

G. Martrat, C. Maxwell, Emiko Tominaga, et al.. (2011). Breast Cancer Research : BCR. Cited 21 times. https://doi.org/10.1186/bcr2862

Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)

Eric Tram, I. Ibrahim-zada, L. Briollais, et al.. (2011). Breast Cancer Research : BCR. Cited 21 times. https://doi.org/10.1186/bcr2926

Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: Potential breast cancer risk alleles and their distribution across human populations

S. Savas, S. Schmidt, H. Jarjanazi, et al.. (2006). Human Genomics. Cited 21 times. https://doi.org/10.1186/1479-7364-2-5-287

Ethnicity, but not cancer family history, is related to response to a population-based mailed questionnaire.

Cristina Mancuso, G. Glendon, L. Anson-Cartwright, et al.. (2004). Annals of epidemiology. Cited 21 times. https://doi.org/10.1016/S1047-2797(03)00073-5

Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.

R. Heisey, Ccfp, June C. Carroll, et al.. (1999). Canadian family physician Medecin de famille canadien. Cited 21 times.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

A. Hollestelle, Frederieke H van der Baan, A. Berchuck, et al.. (2016). Gynecologic oncology. Cited 20 times. https://doi.org/10.1016/j.ygyno.2015.04.034

Disengagement and Social Support Moderate Distress among Women with a Family History of Breast Cancer

J. Turner-Cobb, L. Bloor, A. Whittemore, et al.. (2006). The Breast Journal. Cited 20 times. https://doi.org/10.1111/j.1075-122X.2006.00178.x

Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk.

Wan-lin Yang, A. Godwin, Xiang-Xi Xu. (2004). Cancer research. Cited 20 times.

The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia

Anna J Marsh, A. Spurdle, B. Turner, et al.. (2001). Breast Cancer Research : BCR. Cited 20 times. https://doi.org/10.1186/bcr319

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Jingmei Li, L. Lindström, J. Foo, et al.. (2014). Nature Communications. Cited 19 times. https://doi.org/10.1038/ncomms5051

No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer

A. Spurdle, J. Hopper, Xiaoqing Chen, et al.. (2002). Breast Cancer Research. Cited 19 times. https://doi.org/10.1186/bcr534

The importance of a family history of breast cancer in predicting the presence of a BRCA mutation.

W. Foulkes, J. Brunet, E. Warner, et al.. (1999). American journal of human genetics. Cited 19 times. https://doi.org/10.1086/302675

DDT exposure during pregnancy and DNA methylation alterations in female offspring in the Child Health and Development Study.

Hui-Chen Wu, B. Cohn, P. Cirillo, et al.. (2020). Reproductive toxicology. Cited 19 times. https://doi.org/10.1016/j.reprotox.2019.02.010

Covariate adjustment in family‐based association studies

A. Whittemore, J. Halpern, H. Ahsan. (2005). Genetic Epidemiology. Cited 18 times. https://doi.org/10.1002/GEPI.20055

Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis

Harindra Jayasekara, R. MacInnis, James A Chamberlain, et al.. (2019). International Journal of Cancer. Cited 18 times. https://doi.org/10.1002/ijc.32214

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers

A. Jakubowska, D. Rozkrut, A. Antoniou, et al.. (2010). Breast Cancer Research and Treatment. Cited 17 times. https://doi.org/10.1007/s10549-009-0595-7

A protein‐truncating mutation in CYP17A1 in three sisters with early‐onset breast cancer

J. Hopper, V. Hayes, A. Spurdle, et al.. (2005). Human Mutation. Cited 17 times. https://doi.org/10.1002/humu.20237

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.

V. Beral, D. Bull, R. Doll, et al.. (2004). Lancet. Cited 17 times.

Human breast cancer and lymphomas may share a common aetiology involving Mouse Mammary Tumour Virus (MMTV).

M. Cotterchio, V. Nadalin, M. Sauer. (2002). Medical hypotheses. Cited 17 times. https://doi.org/10.1016/S0306-9877(02)00204-9

Genetic predisposition in gynecologic cancers.

M. Daniels, K. Lu. (2016). Seminars in oncology. Cited 17 times. https://doi.org/10.1053/j.seminoncol.2016.08.005

Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2.

J. Hopper, M. Jenkins. (1999). American journal of human genetics. Cited 17 times. https://doi.org/10.1086/302674

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)

K. Crew, G. Anderson, D. Hershman, et al.. (2019). Cancer Prevention Research. Cited 17 times. https://doi.org/10.1158/1940-6207.CAPR-18-0444

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

F. Qian, M. Rookus, Goska Leslie, et al.. (2019). British Journal of Cancer. Cited 17 times. https://doi.org/10.1038/s41416-019-0492-8

Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry

C. M. Scott, J. Joo, N. O’Callaghan, et al.. (2016). PLoS ONE. Cited 16 times. https://doi.org/10.1371/journal.pone.0165436

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

M. Kabisch, J. Lorenzo Bermejo, Thomas Dünnebier, et al.. (2015). Carcinogenesis. Cited 16 times. https://doi.org/10.1093/carcin/bgu326

The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients

R. Fagerholm, M. Schmidt, Sofia Khan, et al.. (2015). Oncotarget. Cited 16 times. https://doi.org/10.18632/ONCOTARGET.3506

Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer

A. Bradbury, L. Patrick-Miller, Lisa A Schwartz, et al.. (2015). Pediatrics. Cited 16 times. https://doi.org/10.1542/peds.2015-0498

Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry

J. Ferris, M. Daly, S. Buys, et al.. (2014). British Journal of Cancer. Cited 16 times. https://doi.org/10.1038/bjc.2013.803

Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2

T. Nguyen-Dumont, Z. L. Teo, B. Pope, et al.. (2013). BMC Medical Genomics. Cited 16 times. https://doi.org/10.1186/1755-8794-6-48

DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR)

Hui-Chen Wu, L. Delgado-Cruzata, N. Machella, et al.. (2013). Cancer Causes & Control. Cited 16 times. https://doi.org/10.1007/s10552-013-0292-z

Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry

Meghan E. Work, I. Andrulis, E. John, et al.. (2012). Breast Cancer Research and Treatment. Cited 16 times. https://doi.org/10.1007/s10549-012-2056-y

Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry

Yonglan Zheng, T. Ogundiran, C. Adebamowo, et al.. (2012). Breast Cancer Research and Treatment. Cited 16 times. https://doi.org/10.1007/s10549-011-1890-7

Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort

Nur Zeinomar, K. Phillips, M. Daly, et al.. (2019). International Journal of Cancer. Cited 16 times. https://doi.org/10.1002/ijc.32112

Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer

Christine Y. Yeh, Ravali Adusumilli, Majlinda Kullolli, et al.. (2017). Biomarker Research. Cited 15 times. https://doi.org/10.1186/s40364-017-0110-y

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

Xiang Jiao, Christos Aravidis, R. Marikkannu, et al.. (2017). Oncotarget. Cited 15 times. https://doi.org/10.18632/oncotarget.21800

Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry

L. Walker, J. Pearson, G. Wiggins, et al.. (2017). Breast Cancer Research : BCR. Cited 15 times. https://doi.org/10.1186/s13058-017-0825-6

Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry

Nur Zeinomar, Ashley T. Thai, A. Cloud, et al.. (2017). PLoS ONE. Cited 15 times. https://doi.org/10.1371/journal.pone.0189118

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus

Hisani N. Horne, Charles C. Chung, Han Zhang, et al.. (2016). PLoS ONE. Cited 15 times. https://doi.org/10.1371/journal.pone.0160316

Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry.

M. Walker, L. Mirea, G. Glendon, et al.. (2014). Breast. Cited 15 times. https://doi.org/10.1016/j.breast.2014.04.001

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

Kristen S. Purrington, S. Slettedahl, M. Bolla, et al.. (2014). Human molecular genetics. Cited 15 times. https://doi.org/10.1093/hmg/ddu300

Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry

Fang F. Zhang, E. John, J. Knight, et al.. (2012). Breast Cancer Research and Treatment. Cited 15 times. https://doi.org/10.1007/s10549-012-2342-8

High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers

G. Chew, D. Huang, S. Lin, et al.. (2012). Breast Cancer Research and Treatment. Cited 15 times. https://doi.org/10.1007/s10549-012-2128-z

Genetic Variation in Telomere Maintenance Genes, Telomere Length and Breast Cancer Risk

Jing Shen, M. Terry, Y. Liao, et al.. (2012). PLoS ONE. Cited 15 times. https://doi.org/10.1371/journal.pone.0044308

A genome-wide linkage study of mammographic density, a risk factor for breast cancer

C. Greenwood, A. Paterson, L. Linton, et al.. (2011). Breast Cancer Research : BCR. Cited 15 times. https://doi.org/10.1186/bcr3078

Validation study of the lambda model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women

C. Apicella, J. Dowty, G. Dite, et al.. (2007). Clinical Genetics. Cited 15 times. https://doi.org/10.1111/j.1399-0004.2007.00841.x

Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population‐based study

Tengteng Wang, Lauren E. McCullough, Alexandra J. White, et al.. (2019). Cancer. Cited 15 times. https://doi.org/10.1002/cncr.32364

Accuracy of Self-Reported Screening Mammography Use: Examining Recall among Female Relatives from the Ontario Site of the Breast Cancer Family Registry

M. Walker, A. Chiarelli, L. Mirea, et al.. (2013). ISRN Oncology. Cited 14 times. https://doi.org/10.1155/2013/810573

Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

T. Kirchhoff, M. Gaudet, A. Antoniou, et al.. (2012). PLoS ONE. Cited 14 times. https://doi.org/10.1371/journal.pone.0035706

CK8/18 expression, the basal phenotype, and family history in identifying BRCA1‐associated breast cancer in the Ontario site of the Breast Cancer Family Registry

A. Mulligan, Dushanthi Pinnaduwage, A. Bane, et al.. (2011). Cancer. Cited 14 times. https://doi.org/10.1002/cncr.25642

Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women

G. Fehringer, H. Ozçelik, J. Knight, et al.. (2009). Breast Cancer Research and Treatment. Cited 14 times. https://doi.org/10.1007/s10549-008-0146-7

Identification of rare variants in the hLIMD1 gene in breast cancer.

Christopher J. Huggins, M. Gill, I. Andrulis. (2007). Cancer genetics and cytogenetics. Cited 14 times. https://doi.org/10.1016/J.CANCERGENCYTO.2007.06.007

Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies

H. Ozçelik, J. Knight, G. Glendon, et al.. (2003). Journal of Medical Genetics. Cited 14 times. https://doi.org/10.1136/jmg.40.8.e91

Mutation in the coding region of the BRCA1 gene leads to aberrant splicing of the transcript

H. Ozçelik, R. Nedelcu, V. S. Chan, et al.. (1999). Human Mutation. Cited 14 times. https://doi.org/10.1002/(SICI)1098-1004(199912)14:6<540::AID-HUMU13>3.0.CO;2-C

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

Maral Jamshidi, R. Fagerholm, Sofia Khan, et al.. (2015). Oncotarget. Cited 13 times. https://doi.org/10.18632/oncotarget.4991

The Potential for Enhancing the Power of Genetic Association Studies in African Americans through the Reuse of Existing Genotype Data

Gary K. Chen, R. Millikan, E. John, et al.. (2010). PLoS Genetics. Cited 13 times. https://doi.org/10.1371/journal.pgen.1001096

No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers

A. Spurdle, A. Deans, D. Duffy, et al.. (2009). Breast Cancer Research and Treatment. Cited 13 times. https://doi.org/10.1007/s10549-008-0083-5

The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women

K. Montgomery, Jiun-Horng Chang, D. Gertig, et al.. (2005). Breast Cancer Research. Cited 13 times. https://doi.org/10.1186/bcr1009

Genetic Association Studies: Time for a New Paradigm?

A. Whittemore. (2005). Cancer Epidemiology Biomarkers & Prevention. Cited 13 times. https://doi.org/10.1158/1055-9965.EPI-05-0403

Commentary: Case-control-family designs: a paradigm for future epidemiology research?

J. Hopper. (2003). International journal of epidemiology. Cited 13 times. https://doi.org/10.1093/IJE/DYG114

Birthplace and survival among Asian women diagnosed with breast cancer in cancer registry data: the impact of selection bias.

Scarlett S. Lin, C. O’Malley, C. Clarke, et al.. (2002). International journal of epidemiology. Cited 13 times. https://doi.org/10.1093/IJE/31.2.511

More breast cancer genes?

J. Hopper. (2001). Breast Cancer Research. Cited 13 times. https://doi.org/10.1186/bcr290

Hereditary breast cancer. Psychosocial issues and family physicians' role.

J. Carroll, R. Heisey, E. Warner, et al.. (1999). Canadian family physician Medecin de famille canadien. Cited 13 times.

Pilot study of an information aid for women with a family history of breast cancer

E. Warner, V. Goel, N. Ondrusek, et al.. (1999). Health Expectations. Cited 13 times. https://doi.org/10.1046/j.1369-6513.1999.00038.x

Assessing patient readiness for personalized genomic medicine

Caren J. Frost, I. Andrulis, S. Buys, et al.. (2018). Journal of Community Genetics. Cited 13 times. https://doi.org/10.1007/s12687-018-0365-5

In Utero DDT Exposure and Breast Density in Early Menopause by Maternal History of Breast Cancer.

Jasmine A. McDonald, P. Cirillo, P. Tehranifar, et al.. (2020). Reproductive toxicology. Cited 13 times. https://doi.org/10.1016/j.reprotox.2019.08.009

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

J. Lei, A. Rudolph, K. Moysich, et al.. (2015). Human Genetics. Cited 12 times. https://doi.org/10.1007/s00439-015-1616-8

Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility

(2016). Molecular Systems Biology. Cited 12 times. https://doi.org/10.15252/msb.20156506

Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility

Stephen R. Piccolo, I. Andrulis, A. Cohen, et al.. (2015). BMC Medical Genomics. Cited 12 times. https://doi.org/10.1186/s12920-015-0145-6

Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry

G. Dite, E. Makalic, D. Schmidt, et al.. (2012). Breast Cancer Research : BCR. Cited 12 times. https://doi.org/10.1186/bcr3248

How do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study

L. Keogh, B. McClaren, C. Apicella, et al.. (2011). Hereditary Cancer in Clinical Practice. Cited 12 times. https://doi.org/10.1186/1897-4287-9-7

Measuring, and identifying predictors of, women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk

C. Apicella, S. Peacock, L. Andrews, et al.. (2009). British Journal of Cancer. Cited 12 times. https://doi.org/10.1038/sj.bjc.6604910

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study

T. Rebbeck, A. Antoniou, Trinidad Caldés Llopis, et al.. (2009). Breast Cancer Research and Treatment. Cited 12 times. https://doi.org/10.1007/s10549-008-0064-8

The cost-quality trade-off: need for data quality standards for studies that impact clinical practice and health policy.

J. Malin, N. Keating. (2005). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 12 times. https://doi.org/10.1200/JCO.2005.01.912

Participation in the cooperative family registry for breast cancer studies: issues of informed consent.

M. Daly, K. Offit, F. Li, et al.. (2000). Journal of the National Cancer Institute. Cited 12 times. https://doi.org/10.1093/JNCI/92.6.452

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Irene Catucci, P. Radice, R. Milne, et al.. (2016). Breast Cancer Research : BCR. Cited 11 times. https://doi.org/10.1186/s13058-016-0762-9

Assessing absolute changes in breast cancer risk due to modifiable risk factors

A. Quante, J. Herz, A. Whittemore, et al.. (2015). Breast Cancer Research and Treatment. Cited 11 times. https://doi.org/10.1007/s10549-015-3411-6

Genetic Susceptibility to Type 2 Diabetes and Breast Cancer Risk in Women of European and African Ancestry

N. Hou, Yonglan Zheng, E. Gamazon, et al.. (2012). Cancer Epidemiology, Biomarkers & Prevention. Cited 11 times. https://doi.org/10.1158/1055-9965.EPI-11-0979

Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry

Letitia D. Smith, A. Tesoriero, E. Wong, et al.. (2011). Breast Cancer Research : BCR. Cited 11 times. https://doi.org/10.1186/bcr2822

The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women

J. Dowty, F. Lose, M. Jenkins, et al.. (2008). Breast Cancer Research and Treatment. Cited 11 times. https://doi.org/10.1007/s10549-007-9832-0

Is MSH2 a breast cancer susceptibility gene?

E. Wong, A. Tesoriero, G. Pupo, et al.. (2007). Familial Cancer. Cited 11 times. https://doi.org/10.1007/s10689-007-9162-8

An inverse association between ovarian cysts and breast cancer in the breast cancer family registry

J. Knight, E. John, R. Milne, et al.. (2006). International Journal of Cancer. Cited 11 times. https://doi.org/10.1002/ijc.21298

Measures of genotype versus gene products: promise and pitfalls in cancer prevention.

H. Ahsan, A. Rundle. (2003). Carcinogenesis. Cited 11 times. https://doi.org/10.1093/CARCIN/BGG104

Relative risk for genetic associations: the case-parent triad as a variant of case-cohort design.

H. Ahsan, S. Hodge, G. Heiman, et al.. (2002). International journal of epidemiology. Cited 11 times. https://doi.org/10.1093/IJE/31.3.669

Participation rates of Ashkenazi Jews in a colon cancer community‐based screening/prevention study

Mario Cappelli, Mario Cappelli, A. Hunter, et al.. (2002). Clinical Genetics. Cited 11 times. https://doi.org/10.1034/j.1399-0004.2002.610205.x

Why Not Grant Primacy to the Family?

B. Koenig. (2001). The American Journal of Bioethics. Cited 11 times. https://doi.org/10.1162/152651601750417937

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

E. Vigorito, Karoline B. Kuchenbaecker, J. Beesley, et al.. (2016). PLoS ONE. Cited 10 times. https://doi.org/10.1371/journal.pone.0158801

Assessing the goodness of fit of personal risk models

G. Gong, A. Quante, M. Terry, et al.. (2014). Statistics in Medicine. Cited 10 times. https://doi.org/10.1002/sim.6176

Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant

Ofure Obazee, C. Justenhoven, S. Winter, et al.. (2013). Breast Cancer Research and Treatment. Cited 10 times. https://doi.org/10.1007/s10549-013-2448-7

Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario Site of the Breast Cancer Family Registry

P. Ritvo, Sarah A. Edwards, G. Glendon, et al.. (2012). BMC Public Health. Cited 10 times. https://doi.org/10.1186/1471-2458-12-518

Determinants of Preferences for Genetic Counselling in Jewish Women

C. Apicella, S. Peacock, L. Andrews, et al.. (2005). Familial Cancer. Cited 10 times. https://doi.org/10.1007/s10689-005-3871-7

Phenotype‐directed analysis of genotype in early‐onset, familial breast cancers

G. Price, J. Armes, S. Ramus, et al.. (2006). Pathology. Cited 10 times. https://doi.org/10.1080/00313020601024052

Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer

L. Houghton, J. Knight, Ying Wei, et al.. (2019). JAMA Network Open. Cited 10 times. https://doi.org/10.1001/jamanetworkopen.2019.0083

Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?

T. Nguyen-Dumont, Z. L. Teo, F. Hammet, et al.. (2018). BMC Cancer. Cited 9 times. https://doi.org/10.1186/s12885-018-4028-z

Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families

J. Li, Hongyan Li, I. Makunin, et al.. (2017). Breast Cancer Research and Treatment. Cited 9 times. https://doi.org/10.1007/s10549-017-4469-0

Fresh Cut Versus Stored Cut Paraffin-embedded Tissue: Effect on Immunohistochemical Staining for Common Breast Cancer Markers

Catherine L. Forse, Dushanthi Pinnaduwage, S. Bull, et al.. (2019). Applied Immunohistochemistry & Molecular Morphology. Cited 9 times. https://doi.org/10.1097/PAI.0000000000000579

DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.

Hui-Chen Wu, M. Southey, H. Hibshoosh, et al.. (2017). Anticancer research. Cited 9 times. https://doi.org/10.21873/ANTICANRES.11361

Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers

J. Hopper, M. Jenkins, J. Dowty, et al.. (2012). Pathology. Cited 9 times. https://doi.org/10.1097/PAT.0b013e32834e8e5b

Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour

E. Wong, J. Joo, C. Mclean, et al.. (2016). Breast Cancer Research and Treatment. Cited 8 times. https://doi.org/10.1007/s10549-016-3971-0

A Genome-Wide “Pleiotropy Scan” Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer

D. Campa, Myrto Barrdahl, K. Tsilidis, et al.. (2014). PLoS ONE. Cited 8 times. https://doi.org/10.1371/journal.pone.0085955

EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry

A. Bane, A. Mulligan, Dushanthi Pinnaduwage, et al.. (2011). Breast Cancer Research and Treatment. Cited 8 times. https://doi.org/10.1007/s10549-011-1380-y

Availability and Accuracy of Medical Record Information on Language Usage of Cancer Patients from a Multi-Ethnic Population

L. McClure, S. Glaser, S. Shema, et al.. (2010). Journal of Immigrant and Minority Health. Cited 8 times. https://doi.org/10.1007/s10903-009-9282-3

Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development

Jianjun Liu, K. Desai, Yuqing Li, et al.. (2009). The HUGO Journal. Cited 8 times. https://doi.org/10.1007/s11568-010-9138-x

Re: On the use of familial aggregation in population-based case probands for calculating penetrance.

A. Whittemore, G. Gong. (2003). Journal of the National Cancer Institute. Cited 8 times. https://doi.org/10.1093/JNCI/95.1.76

Genetic association tests for family data with missing parental genotypes: A comparison

A. Whittemore, J. Halpern. (2003). Genetic Epidemiology. Cited 8 times. https://doi.org/10.1002/GEPI.10247

Re: "Presenting statistical uncertainty in trends and dose-response relations".

J. Hopper, G. Dite. (2002). American journal of epidemiology. Cited 8 times. https://doi.org/10.1093/AJE/155.10.977

ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry

Anne-Laure Renault, F. Lesueur, Yan Coulombe, et al.. (2016). PLoS ONE. Cited 7 times. https://doi.org/10.1371/journal.pone.0156820

Mammographic density and breast cancer: a comparison of related and unrelated controls in the Breast Cancer Family Registry

L. Linton, L. Martin, Qing Li, et al.. (2013). Breast Cancer Research : BCR. Cited 7 times. https://doi.org/10.1186/bcr3430

The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant

C. Justenhoven, Ofure Obazee, S. Winter, et al.. (2011). Breast Cancer Research and Treatment. Cited 7 times. https://doi.org/10.1007/s10549-011-1827-1

Racial and Ethnic Differences in Adjuvant Hormonal Therapy Use

J. Livaudais, Christopher I. Li, Christopher I. Li, et al.. (2012). Journal of Women's Health. Cited 7 times. https://doi.org/10.1089/jwh.2011.3254

Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer

B. Kiely, M. Friedlander, R. Milne, et al.. (2011). Familial Cancer. Cited 7 times. https://doi.org/10.1007/s10689-011-9435-0

The accuracy of cancer diagnoses as reported in families with head and neck cancer: a case-control study.

S. Jefferies, D. E. Goldgar, R. Eeles. (2008). Clinical oncology (Royal College of Radiologists (Great Britain)). Cited 7 times. https://doi.org/10.1016/j.clon.2008.01.008

Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

J. Hopper, J. Baron. (2003). Journal of the National Cancer Institute. Cited 7 times. https://doi.org/10.1093/JNCI/95.13.1010

New Ontario familial breast cancer registry to facilitate genetic and epidemiologic studies.

I. Andrulis, N. Boyd, H. Sutherland. (1997). Canadian family physician Medecin de famille canadien. Cited 7 times.

Body size at birth, early-life growth and the timing of the menopausal transition and natural menopause.

M. Goldberg, H. Tawfik, J. Kline, et al.. (2020). Reproductive toxicology. Cited 7 times. https://doi.org/10.1016/j.reprotox.2019.02.013

Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots.

T. Nguyen-Dumont, M. Mahmoodi, F. Hammet, et al.. (2015). Analytical biochemistry. Cited 6 times. https://doi.org/10.1016/j.ab.2014.10.010

Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers

Kristen Stevens, Xianshu Wang, Z. Fredericksen, et al.. (2012). Breast Cancer Research and Treatment. Cited 6 times. https://doi.org/10.1007/s10549-012-2255-6

7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium

R. Milne, J. Lorenzo-Bermejo, B. Burwinkel, et al.. (2011). Journal of Medical Genetics. Cited 6 times. https://doi.org/10.1136/jmedgenet-2011-100303

Professional opportunities and responsibilities in the provision of genetic information to children relinquished for adoption

V. Venne, J. Botkin, S. Buys. (2003). American Journal of Medical Genetics Part A. Cited 6 times. https://doi.org/10.1002/ajmg.a.20071

Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction

Molly Scannell Bryan, Maria Argos, I. Andrulis, et al.. (2017). Breast Cancer Research and Treatment. Cited 5 times. https://doi.org/10.1007/s10549-017-4287-4

Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry

M. Walker, L. Mirea, K. Cooper, et al.. (2013). Familial Cancer. Cited 5 times. https://doi.org/10.1007/s10689-013-9689-9

Human subjects protection: an event monitoring committee for research studies of girls from breast cancer families.

Diana Harris, L. Patrick-Miller, Lisa A Schwartz, et al.. (2014). The Journal of adolescent health : official publication of the Society for Adolescent Medicine. Cited 5 times. https://doi.org/10.1016/j.jadohealth.2014.03.007

Are genetic and environmental components of variance in mammographic density measures that predict breast cancer risk independent of within-twin pair differences in body mass index?

G. Dite, J. Stone, A. Chiarelli, et al.. (2011). Breast Cancer Research and Treatment. Cited 5 times. https://doi.org/10.1007/s10549-011-1739-0

Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk

Kristen Stevens, M. García-Closas, Z. Fredericksen, et al.. (2011). British Journal of Cancer. Cited 5 times. https://doi.org/10.1038/bjc.2011.448

Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk

G. Fehringer, N. Boyd, J. Knight, et al.. (2009). Breast Cancer Research and Treatment. Cited 5 times. https://doi.org/10.1007/s10549-009-0336-y

Re: On the use of familial aggregation in population-based case probands for calculating penetrance.

P. Pharoah, A. Antoniou, J. Hopper, et al.. (2003). Journal of the National Cancer Institute. Cited 5 times. https://doi.org/10.1093/JNCI/95.1.75

Early-life Growth and Benign Breast Disease.

M. Goldberg, B. Cohn, L. Houghton, et al.. (2019). American journal of epidemiology. Cited 5 times. https://doi.org/10.1093/aje/kwz126

Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer

G. Dite, R. MacInnis, A. Bickerstaffe, et al.. (2017). American Journal of Epidemiology. Cited 4 times. https://doi.org/10.1093/aje/kww241

A qualitative study evaluating parental attitudes towards the creation of a female youth cohort (LEGACY) in the Breast Cancer Family Registry

G. Glendon, Caren J. Frost, I. Andrulis, et al.. (2010). Psycho‐Oncology. Cited 4 times. https://doi.org/10.1002/pon.1543

Socio‐economic status and survival from breast cancer for young, Australian, urban women

K. Morley, R. Milne, Graham G. Giles, et al.. (2010). Australian and New Zealand Journal of Public Health. Cited 4 times. https://doi.org/10.1111/j.1753-6405.2010.00507.x

No evidence of familial correlation in breast cancer metastasis

A. Whittemore, B. Stearman, V. Venne, et al.. (2009). Breast Cancer Research and Treatment. Cited 4 times. https://doi.org/10.1007/s10549-009-0368-3

Genome Wide Screening of CAG Trinucleotide Repeat Lengths in Breast Cancer

H. Jarjanazi, Hong Li, I. Andrulis, et al.. (2007). Disease Markers. Cited 3 times. https://doi.org/10.1155/2006/951857

Distribution of family history of a disease as a function of mode of inheritance, genetic relative hazard, allele frequency and disease status of the proband, with application to female breast cancer.

J. Cui, J. Hopper. (2001). Journal of epidemiology and biostatistics. Cited 3 times. https://doi.org/10.1080/13595220152601800

Performance of BCRAT in high-risk patients with breast cancer - Authors' reply.

M. Terry, Y. Liao, J. Hopper, et al.. (2019). The Lancet. Oncology. Cited 3 times. https://doi.org/10.1016/S1470-2045(19)30311-0

Quantifying the cumulative effect of low-penetrance genetic variants on breast cancer risk

Conor Smyth, Iva Špakulová, Owen Cotton-Barratt, et al.. (2015). Molecular Genetics & Genomic Medicine. Cited 2 times. https://doi.org/10.1002/mgg3.129

Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults

Fang Chen, Jing He, Jianqi Zhang, et al.. (2015). PLoS ONE. Cited 2 times. https://doi.org/10.1371/journal.pone.0131106

Is BRCA2 c.9079 G > A a predisposing variant for early onset breast cancer?

F. Hammet, J. George, A. Tesoriero, et al.. (2008). Breast Cancer Research and Treatment. Cited 2 times. https://doi.org/10.1007/s10549-007-9624-6

Response to ten Broeke et al.

M. Roberts, Nur Zeinomar, B. Solomon, et al.. (2018). Genetics in Medicine. Cited 2 times. https://doi.org/10.1038/s41436-018-0031-7

Response to Lee et al 2019: Essential to frame study implications within the context of prior findings from enriched cohorts for underlying familial risk of breast cancer

M. Terry, Nur Zeinomar. (2019). Occupational and Environmental Medicine. Cited 2 times. https://doi.org/10.1136/oemed-2019-105936

Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.

R. MacInnis, M. Pike, J. Hopper. (2016). The New England journal of medicine. Cited 1 times. https://doi.org/10.1056/NEJMc1602861

Placental genes and breast cancer: can the offspring's or father's genotypes predict mother's risk?

H. Ahsan. (2003). Epidemiology. Cited 1 times. https://doi.org/10.1097/01.EDE.0000050696.19411.C0

Modified rapid expansion detection method to analyze Cag/CTG repeat expansions.

H. Jarjanazi, H. Ozçelik. (2002). BioTechniques. Cited 1 times. https://doi.org/10.2144/02325BM06

Response to Evans et al.

M. Roberts, Nur Zeinomar, B. Solomon, et al.. (2018). Genetics in Medicine. Cited 1 times. https://doi.org/10.1038/s41436-018-0400-2

Interpretation of genomic variation and disease association: the great missense mutation challenge!

T. Nguyen-Dumont, I. Winship, M. Southey. (2015). Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-015-3394-3

Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society. Breast Cancer Working Group.

B. A. Koenig, H. T. Greely, L. M. McCONNELL, et al.. (1998). Journal of women's health.

Transient tumor marker surge following chemotherapy of testis tumors.

M. R. Shetty. (1987). Cancer treatment reports.

Response to Wang et al.

M. Roberts, Nur Zeinomar, B. Solomon, et al.. (2019). Genetics in Medicine. https://doi.org/10.1038/s41436-019-0469-2